WO2014108011A1 - Entecavir intermediates and preparation method thereof - Google Patents

Entecavir intermediates and preparation method thereof Download PDF

Info

Publication number
WO2014108011A1
WO2014108011A1 PCT/CN2013/089175 CN2013089175W WO2014108011A1 WO 2014108011 A1 WO2014108011 A1 WO 2014108011A1 CN 2013089175 W CN2013089175 W CN 2013089175W WO 2014108011 A1 WO2014108011 A1 WO 2014108011A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
formula
group
give
reaction
Prior art date
Application number
PCT/CN2013/089175
Other languages
French (fr)
Chinese (zh)
Inventor
刘念
牟祥
李倩
Original Assignee
重庆康施恩化工有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 重庆康施恩化工有限公司 filed Critical 重庆康施恩化工有限公司
Publication of WO2014108011A1 publication Critical patent/WO2014108011A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Definitions

  • the invention relates to a hepatitis B drug intermediate and a preparation method thereof, in particular to a key intermediate of entecavir, a methylene cyclopentane compound and a preparation method thereof.
  • Entecavir an antiviral (HBV) prescription drug, was first marketed in the United States in April 2005 by Bristol-Myers Squibb.
  • the chemical name is: [IS- (1 ⁇ , 3 ⁇ , 4 ⁇ )]-2-yl-1,9-dihydro[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclo] ⁇ 611- ⁇ -6-one;
  • JOC 1985 (50) 755, CN1061972, WO9809964, CN1747959, etc. describe the preparation method thereof, the key is to synthesize the key intermediate cyclopentane compound, and the intermediate has the following problems.
  • the preparation method is achiral cyclopentane.
  • the olefin is the starting material, and the chiral group is constructed by using an expensive chiral ligand or chiral resolution, and the introduction of the chiral group is low in efficiency and high in cost.
  • CN1747959 also reports the use of silane as a precursor of a hydroxyl group. After completing the basic structural synthesis of the target molecule, the conversion of the silane group to a hydroxyl group is accomplished using very severe oxidation conditions, so that the purity and yield are not high, and A special resin is required to separate.
  • Tetra edron 59 (2003) 9013-9018 reports a synthesis method for the synthesis of entecavir intermediate methylene cyclopentane.
  • the core of the method is to open the epoxy through chlorotitanium titanate and combine with acetylene to obtain a ring-closing product.
  • the ring closure yield is as high as 82%.
  • this method has the following problems - First, it is necessary to use a highly toxic organotin to remove the 2-position hydroxyl group of glucose.
  • nucleophilic attack can occur due to the positions of 9-N and 7-N. Although the 9-N selectivity is greater than 7-N, the reaction product of 7-N is unavoidable.
  • alkyl denotes a straight or branched monovalent glucone and a hydrocarbon group consisting of carbon and hydrogen atoms.
  • C1-6 alkyl means a branched or straight-chain alkyl group of 1 to 6 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, ft butyl , n-hexane.
  • Haloalkyl means an alkyl group as defined above substituted by one or more halogens, for example trifluoromethyl.
  • alkoxy alone or in combination with other groups, denotes a group R-0-, wherein R is alkyl as defined above.
  • C1-6 alkoxy means a group R'-0-, wherein R' is a C1-6 fluorenyl group as captured above.
  • Aryl means a monocyclic or fused ring bicyclic aromatic ring containing a carbon atom.
  • C5-10 aryl means an aryl group having 5 to 10 carbon atoms.
  • the C5-10 aryl group can be phenyl or naphthyl.
  • Alkyl means an alkyl group as described above substituted with an aryl group as described above.
  • Acyl refers to the group -CO-R, wherein R is alkyl, aryl, aralkyl as described above.
  • aryl groups described above may be optionally substituted with one or more substituents.
  • the substituent is preferably selected from the group consisting of C1-6 alkyl, Cl>6 alkoxy, halogen, aryl and nitro, more preferably selected from methoxy, ethoxy, Halogen, phenyl and nitro.
  • the present invention provides new synthetic methods including -
  • PI and P3 may be the same or different and each represent hydrogen, an alkoxycarbonyl or an aralkoxy-Wei group;
  • P2 is selected from the group consisting of C1-6 alkyl, haloalkyl, benzyl, t-BuMe 2 Si, t-BuP3 ⁇ 4Si, Et 3 Si, benzoyl, tetrapyran-2-yl, substituted with a phenyl ring Benzoyl, biphenyl "4-formyl"; the epoxy stereo configuration of the compound of Formula 2 may be in the R-configuration, the S-configuration or the 3 ⁇ 4S-configuration.
  • the preparation method of the compound 1 is prepared by the following method - preparing the compound of the formula 13 by double-base protection under Lewis acid catalysis,
  • R1 is a hydrogen atom, a C1-6 alkyl group, a phenyl group or a substituted phenyl group, and the substituent on the phenyl group is preferably selected from the group consisting of a methoxy group, an ethoxy group, a halogen group, a phenyl group and a nitro group;
  • the compound of formula 12 is selectively deprotected from a hydroxy protecting group under polar conditions in a polar protic solvent.
  • Rl, P4 are defined as described above;
  • the compound of the formula 11 is obtained by the oxidation reaction and the elimination reaction in the polar preparation to obtain the formula 10
  • R1 is defined as described above;
  • R1 is defined as described above;
  • R2 is methylsulfonyl or p-toluenesulfonyl, and P1 and P3 are as defined above;
  • PK P3 is defined as above;
  • PI, P3 are defined as described above;
  • a compound of the formula 3 is reacted with a hydroxy protecting reagent to give a compound of the formula 1.
  • Another preparation method of compound 5 is as follows - a base protecting reagent is reacted to obtain a compound of formula 22, Wherein: R1 is a C1-6 alkyl group, an aryl group, a substituted aryl group, and an aralkyl group;
  • is a 3 ⁇ 4-based activating group, and R1 is as defined above;
  • the compound is reacted with a halogenating reagent to prepare a compound of the formula 20,
  • R1 is defined as described above;
  • X is a halogen, and P1 and P3 are defined as defined above;
  • Compound 1 can also be prepared by the following method.
  • the compound is hydrolyzed by a Mitsunobu reaction to give a compound of the formula 32.
  • PI, P2 are defined as described above;
  • R2 is hydrogen, an organometallic ion such as sodium, a weight, a potassium ion, and a 'grac group, an aralkyl group, an substituted aralkyl group on the aromatic ring, and R1, P1, and ⁇ 2 are as defined above;
  • Rl, Pl, P2, P3 are defined as above;
  • Rl, PI, P2, P3 are defined as described above;
  • PI, P2, P3 are defined as described above;
  • the compound of the formula 24 is oxidized to give a compound of the formula 2.
  • the epoxy stereo configuration can be R-configuration, S-configuration or R, S-configuration.
  • reaction temperature 20-3 (TC).
  • Ethyl diethylaminoethyl malonate (258 g l. Wmol, leq), 3 L of tetrahydrofuran, potassium tert-butoxide (146 g, 1.30 mol, 1.09 eq), refluxed for 1 hour, and added 5 (M) mL of tetrahydrogen
  • the 19a (300 g, l, 19 mol, l eq) dissolved in the sputum was added for 10 minutes, refluxed for 2.5 hours, and the remaining 20% of TLC was still added, supplemented with diethyl acetamidomalonate (100 g 0.47 mol, 0.39eq) and butanol C58g, 0.417mol, 0.39eq), after refluxing for 10 hours, no T2 in TLC, cooled to room temperature, filtered, concentrated under reduced pressure to 1L, then added 2L ethyl acetate, 0.1N 1 L of hydrochloric acid was washed, was
  • 29a (30 g, 72.18 mmol» leq) was added, 300 g of tetrahydrofuran was added, and the temperature was lowered to 0. °C, add lithium oxide (11.6g, 277.8mmol, 3.84 eq), add and maintain at this temperature for 2-3 hours, HPLC control without 29a, 0.5N potassium hydrogen sulfate solution to adjust the pH to 6- After concentrating between methanol, ethyl acetate was extracted, dried, and concentrated to give 28 g of white solid 28a, yield 85%.
  • potassium tert-butoxide (7 g, 62.9 mmol, 1.61 eq) was added to a 500 mL reaction flask, and anhydrous 100 mL of tetrahydrofuran was added to cool to 5-10 ° C, and methyltriphenyl bromide (23.6 g was added).

Abstract

The present invention relates to important intermediate 2 of entecavir and a method for preparing entecavir intermediate compound 1 through ring-closing reaction of compound 2 under the condition of free radicals with transition metals as the center.

Description

恩替卡韦中间体及其制备方法 技术领域  Entecavir intermediate and preparation method thereof
本发明涉及乙肝药物中间体及其制备方法,具体的是恩替卡韦关键中间体亚 甲基环戊烷化合物及其制备方法。  The invention relates to a hepatitis B drug intermediate and a preparation method thereof, in particular to a key intermediate of entecavir, a methylene cyclopentane compound and a preparation method thereof.
背景技术 Background technique
恩替卡韦 (Entecavir)—种抗病毒 (HBV) 的处方药, 2005年 4月由百时 美施贵宝公司 (Bristol-MyersSquibb)在美国首先上市。 化学名称为: [IS- (1 α , 3 α , 4 § )]-2-氣基-1,9-二氢 [4-羟基-3-(羟甲基)-2-亚甲环 基]~611-嘌呤-6-酮;  Entecavir, an antiviral (HBV) prescription drug, was first marketed in the United States in April 2005 by Bristol-Myers Squibb. The chemical name is: [IS- (1 α , 3 α , 4 § )]-2-yl-1,9-dihydro[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclo] ~611-嘌呤-6-one;
Figure imgf000002_0001
关于其作为抗病毒药物用途的报道首见 US526244; 恩替卡韦低剂量药物组 合用于治疗乙型肝炎病毒感染的报道见 CN1310999 和 CN1658844。
Figure imgf000002_0001
For the first report on its use as an antiviral drug, US526244; entecavir low-dose combination of drugs for the treatment of hepatitis B virus infection can be found in CN1310999 and CN1658844.
JOC1985(50)755、 CN1061972, WO9809964, CN1747959等描述了其制备方法, 关键是通过合成关键中间体环戊烷化合物, 而该中间体存在以下问题 第一、制备方法以非手性的环戊二烯为起始物料,通过使用昂贵的手性配体或手 性拆分构建手性基团, 此类引入手性基团的效率低, 成本高。 JOC 1985 (50) 755, CN1061972, WO9809964, CN1747959, etc. describe the preparation method thereof, the key is to synthesize the key intermediate cyclopentane compound, and the intermediate has the following problems. First, the preparation method is achiral cyclopentane. The olefin is the starting material, and the chiral group is constructed by using an expensive chiral ligand or chiral resolution, and the introduction of the chiral group is low in efficiency and high in cost.
第二、 在接下 与鸟嘌呤衍生物的反应中收率低, 其中 JOC1985(50)755 , 报道 的收率仅为 27%。 Second, the yield in the next reaction with the guanine derivative was low, of which JOC 1985 (50) 755 reported a yield of only 27%.
第三、鸟嘌呤幵环位置选择及手性选择性较差,幵环后存在多个立体异构体混合, 即使通过多次柱层析也很难制备高纯度的产物。 例如 WO980996报道开环产物 经过多次硅胶柱分离后得到纯度也仅有 92%产物。 Third, the position selection and chiral selectivity of the guanine ring are poor, and multiple stereoisomers are mixed after the anthracene ring, and it is difficult to prepare a high-purity product even by multiple column chromatography. For example, WO980996 reports that the ring-opening product is separated by multiple silica gel columns to give a purity of only 92%.
第四、开环后的产物在接下来的反应中需进一歩对鸟嘌昤上的氨基进行保护,保 护反应困难, 产物不稳定, 即使在硅胶柱上也很容易分解, 提纯困难。 第五、 CN1747959 中还报道了使用硅烷作为羟基的前体, 在完成目标分子的基 本结构合成之后,使用非常苛刻的氧化条件完成硅烷基团转化为羟基,因而纯度 和收率都不高, 且需要特殊的树脂来分离。 Fourth, the product after ring opening needs to be protected in the next reaction to protect the amino group on the guanine. The protection reaction is difficult, the product is unstable, and it is easily decomposed even on the silica gel column, and purification is difficult. Fifth, CN1747959 also reports the use of silane as a precursor of a hydroxyl group. After completing the basic structural synthesis of the target molecule, the conversion of the silane group to a hydroxyl group is accomplished using very severe oxidation conditions, so that the purity and yield are not high, and A special resin is required to separate.
因此, 直接使用此方法制备恩替卡韦工艺复杂, 收率低, 反应条件苛刻不适 合工业化生产。  Therefore, the direct use of this method for the preparation of entecavir is complicated, the yield is low, and the reaction conditions are harsh and unsuitable for industrial production.
Tetra edron59(2003)9013-9018报道了一种合成恩替卡韦中间体亚甲基环戊 烷的合成方法,该方法的核心是通过一氯二茂钛打开环氧后与炔键结合得到关环 产物, 关环收率高达 82%。但该方法存在以下问题- 第一、 需使用高毒性的有机锡脱掉葡萄糖的 2-位羟基。  Tetra edron 59 (2003) 9013-9018 reports a synthesis method for the synthesis of entecavir intermediate methylene cyclopentane. The core of the method is to open the epoxy through chlorotitanium titanate and combine with acetylene to obtain a ring-closing product. The ring closure yield is as high as 82%. However, this method has the following problems - First, it is necessary to use a highly toxic organotin to remove the 2-position hydroxyl group of glucose.
第二、 得到环戊烷中间体在脱掉 2-位羟基保护基时不可避免 4-位羟基也被脱 掉, 得到的产物需柱层析分离。 Second, when the cyclopentane intermediate is obtained, the 4-position hydroxyl group is inevitably removed when the 2-hydroxyl protecting group is removed, and the obtained product is separated by column chromatography.
第三、 与鸟嘌呤通过 Mitemo¾u反应时, 因 9-N和 7-N两个位置可以发生亲核 进攻, 虽然 9-N选择性大于 7-N, 但不可避免得到 7-N的反应产物。 Third, when reacting with guanine through Mitemo3⁄4u, nucleophilic attack can occur due to the positions of 9-N and 7-N. Although the 9-N selectivity is greater than 7-N, the reaction product of 7-N is unavoidable.
因此此方法也不适合工业化生产。 Therefore, this method is also not suitable for industrial production.
我们通过首次合成式 2所示化合物,然后在该条件下关环式 1所示恩替卡韦 重要中间体, 此方法能有效克服上述缺点  By combining the compound of formula 2 for the first time and then closing the important intermediate of entecavir shown in formula 1 under this condition, this method can effectively overcome the above disadvantages.
发明内容 Summary of the invention
本发明中, 相关术语定义如下:  In the present invention, related terms are defined as follows:
单独或与其它基团组合的术语 "烷基"表示由碳和氢原子组成的直链或支链 的单价葡和烃基团。 "C1-6烷基"表示由 1至 6个碳原子的支链或直链烷基, 例 如甲基、 乙基、 正丙基、异丙基、 正丁基、 仲丁基、 ft丁基、 正己烷。  The term "alkyl", alone or in combination with other groups, denotes a straight or branched monovalent glucone and a hydrocarbon group consisting of carbon and hydrogen atoms. "C1-6 alkyl" means a branched or straight-chain alkyl group of 1 to 6 carbon atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, ft butyl , n-hexane.
素"是指氟、 氯、 溴和碘。  "" refers to fluorine, chlorine, bromine and iodine.
"卤代烷基"表示被一个或多个卤素取代的如上所定义的烷基, 例如三氟甲 基。  "Haloalkyl" means an alkyl group as defined above substituted by one or more halogens, for example trifluoromethyl.
单独或与其他基团组合的术语 "烷氧基"表示基团 R-0-, 其中 R是如上所述的 烷基。 "C1- 6烷氧基 "表示基团 R' -0-, 其中 R' 是如上所逮的 C1-6垸基。 The term "alkoxy", alone or in combination with other groups, denotes a group R-0-, wherein R is alkyl as defined above. "C1-6 alkoxy" means a group R'-0-, wherein R' is a C1-6 fluorenyl group as captured above.
"芳基"是指含有碳原子的单环或稠环双环的芳香环。 "C5-10芳基"是指含 有 5-10个碳原子的芳基。 例如, C5-10芳基可以是苯基或者萘基。  "Aryl" means a monocyclic or fused ring bicyclic aromatic ring containing a carbon atom. "C5-10 aryl" means an aryl group having 5 to 10 carbon atoms. For example, the C5-10 aryl group can be phenyl or naphthyl.
"芳烷基"是指被如上所述的芳基取代的如上所述的烷基。 "酰基 "是指基团 -CO- R, 其中 R为如上所述的烷基、 芳基、 芳烷基。 "Aralkyl" means an alkyl group as described above substituted with an aryl group as described above. "Acyl" refers to the group -CO-R, wherein R is alkyl, aryl, aralkyl as described above.
以上所述的芳基,无论是作为基团本身,还是作为其它基团例如芳垸基、芳垸氧 基的一部分,均可以任选地被一个或者多个取代基所取代。当所述的芳基被取代 时, 所述取代基优先选自 C1-6烷基、 Cl>6烷氧基、 卤素、 芳基和硝基, 更优先 选自甲氧基、 乙氧基、 卤素、 苯基和硝基。 The aryl groups described above, whether as a group itself or as part of other groups such as an aryl fluorenyl group, an aryl fluorenyl group, may be optionally substituted with one or more substituents. When the aryl group is substituted, the substituent is preferably selected from the group consisting of C1-6 alkyl, Cl>6 alkoxy, halogen, aryl and nitro, more preferably selected from methoxy, ethoxy, Halogen, phenyl and nitro.
本发明的目的在于提供恩替卡韦的中间体及其制备方法。 It is an object of the present invention to provide an intermediate of entecavir and a process for the preparation thereof.
本发明提供新的合成方法包括 -The present invention provides new synthetic methods including -
1. 化合物 2与过渡金属三价德为中心的自由基关环反应制备式 1所示化合 1. Compound 2 and the transition metal trivalent German-centered radical ring-closing reaction to prepare the compound shown in Formula 1
Figure imgf000004_0001
Figure imgf000004_0001
其中: among them:
PI , P3可以相同或不同, 分别代表氢、 烷氧基羰基或者芳烷氧基魏基;  PI and P3 may be the same or different and each represent hydrogen, an alkoxycarbonyl or an aralkoxy-Wei group;
P2选自 C1-6烷基, 卤代烷基、苄基、 t- BuMe2Si 、 t-BuP¾Si 、 Et3Si、 苯甲酰 基、 四氣吡喃 -2-基、 苯环上带有取代基的苯甲酰基、 联苯《4-甲酰基; 式 2所示化合物环氧立体构型可为 R-构型, S-构型或 ¾S-构型。 P2 is selected from the group consisting of C1-6 alkyl, haloalkyl, benzyl, t-BuMe 2 Si, t-BuP3⁄4Si, Et 3 Si, benzoyl, tetrapyran-2-yl, substituted with a phenyl ring Benzoyl, biphenyl "4-formyl"; the epoxy stereo configuration of the compound of Formula 2 may be in the R-configuration, the S-configuration or the 3⁄4S-configuration.
2, 化合物 1的制备方法通过下述方法制备- 在路易斯酸催化下双 基保护制备式 13所示化合物,
Figure imgf000004_0002
2, the preparation method of the compound 1 is prepared by the following method - preparing the compound of the formula 13 by double-base protection under Lewis acid catalysis,
Figure imgf000004_0002
其中: R1为氢原子、 C1-6烷基、 苯基或者带有取代基的苯基, 苯基上的取代基 优先选自甲氧基、 乙氧基、 卤素、 苯基和硝基; Wherein: R1 is a hydrogen atom, a C1-6 alkyl group, a phenyl group or a substituted phenyl group, and the substituent on the phenyl group is preferably selected from the group consisting of a methoxy group, an ethoxy group, a halogen group, a phenyl group and a nitro group;
性条件下反应得到式 12所示化合物, P4为酰基, R1如上所述定义;
Figure imgf000004_0003
Under the conditions of the reaction, the compound of the formula 12 is obtained, P4 is an acyl group, and R1 is as defined above;
Figure imgf000004_0003
c 式 12所示化合物在 «性条件下, 极性质子溶剂中选择性脱去羟基保护基
Figure imgf000005_0001
c The compound of formula 12 is selectively deprotected from a hydroxy protecting group under polar conditions in a polar protic solvent.
Figure imgf000005_0001
其中: Rl, P4如上所述定义; Where: Rl, P4 are defined as described above;
d. 式 11所示化合物在极性清剂中通过氧化反应及消除反应得到式 10所示化
Figure imgf000005_0002
d. The compound of the formula 11 is obtained by the oxidation reaction and the elimination reaction in the polar preparation to obtain the formula 10
Figure imgf000005_0002
10  10
其中: R1如上所述定义; Where: R1 is defined as described above;
物还原得到式 9所示化合物,
Figure imgf000005_0003
Reduction of the compound to give a compound of the formula 9,
Figure imgf000005_0003
I  I
其中: R1如上所述定义; Where: R1 is defined as described above;
物在酸性条件下得到式 8所示化合物的铵  Obtaining the ammonium of the compound of formula 8 under acidic conditions
在碱性条件下与氨基保护试剂反应得到式 7所示化合物,
Figure imgf000005_0004
Reacting with an amino protecting reagent under basic conditions to give a compound of formula 7
Figure imgf000005_0004
其中: Pl、 P3如上所述定义;Where: Pl, P3 are defined as described above;
. 式 7所示化合物在羟基活化剂存在下得到式 6所示化合物 ,
Figure imgf000006_0001
a compound of the formula 7 which gives a compound of the formula 6 in the presence of a hydroxyl activator,
Figure imgf000006_0001
其中: R2为甲磺酰基、 对甲苯磺酰基, Pl、 P3如上所述定义; Wherein: R2 is methylsulfonyl or p-toluenesulfonyl, and P1 and P3 are as defined above;
在碱性条件下关环得到化合物 5,
Figure imgf000006_0002
Closing the ring under basic conditions to give compound 5,
Figure imgf000006_0002
其中: PK P3如上所途定义; Where: PK P3 is defined as above;
还原得到式 4所示化合物,
Figure imgf000006_0003
Reduction to give a compound of formula 4,
Figure imgf000006_0003
其中: PI, P3如上所述定义; Where: PI, P3 are defined as described above;
k. 式 4所示化合物与 Bestmann- Ohira试剂反应得到式 3所示化合物, k. The compound of formula 4 is reacted with a Bestmann- Ohira reagent to give a compound of formula 3,
Figure imgf000006_0004
Figure imgf000006_0004
其中: Pl, P3如上所述定义; Where: Pl, P3 are defined as described above;
1. 式 3所示化合物与羟基保护试剂反应得到式 1所示化合物。  1. A compound of the formula 3 is reacted with a hydroxy protecting reagent to give a compound of the formula 1.
3. 化合物 5另一种制备方法如下- 基保护试剂反应得到式 22所示化合物,
Figure imgf000006_0005
其中: R1为 C1-6烷基、 芳基、 取代的芳基以及芳烷基;
3. Another preparation method of compound 5 is as follows - a base protecting reagent is reacted to obtain a compound of formula 22,
Figure imgf000006_0005
Wherein: R1 is a C1-6 alkyl group, an aryl group, a substituted aryl group, and an aralkyl group;
b. 式 22所示化合物与羟基活化试剂反应生成式 21所示化合物,
Figure imgf000007_0001
b. a compound of formula 22 is reacted with a hydroxyl activating reagent to form a compound of formula 21,
Figure imgf000007_0001
其中: ^为¾基活化基团, R1如上所述定义; Wherein: ^ is a 3⁄4-based activating group, and R1 is as defined above;
合物与卤代试剂反应制备式 20所示化合物,
Figure imgf000007_0002
The compound is reacted with a halogenating reagent to prepare a compound of the formula 20,
Figure imgf000007_0002
20  20
其中: X为卤素, 优选溴; R1如上所述定义;  Wherein: X is a halogen, preferably bromine; R1 is as defined above;
d. 式 20所示化合物与乙酰氣基丙二酸二乙酯在碱性试剂存在下反应得到式 19化合物, d. a compound of the formula 20 is reacted with acetyl aldehyde malonate in the presence of an alkaline reagent to give a compound of the formula 19,
AOHN COOEt  AOHN COOEt
RiOCO ¾00Β 19  RiOCO 3⁄400Β 19
其中: R1定义如上所述; Where: R1 is defined as described above;
解脱羧得式 18所示化合物;
Figure imgf000007_0003
Decarboxylation to give the compound of formula 18;
Figure imgf000007_0003
11  11
f. 式 18所示化合物在 L-乙截化酶条件下拆分,再上保护基得到式 17所示化 合物,f. The compound of formula 18 is resolved under L-ethylidene dilating enzyme, and the protecting group is further added to obtain the compound of formula 17,
ΡιΡ3 ΡιΡ 3
"COOH 其中: PI, P3定义如上所述定义;  "COOH where: PI, P3 are defined as defined above;
Lindlar催化剂存在下加氢得式 ½所示化合物,
Figure imgf000007_0004
其中: Pl, P3定义如上所述定义;
Hydrogenation of the compound of formula 1 in the presence of a Lindlar catalyst,
Figure imgf000007_0004
Where: Pl, P3 are defined as defined above;
关环得到式 15所示化合物,
Figure imgf000008_0001
Closing the ring to obtain the compound of formula 15,
Figure imgf000008_0001
15  15
其中: X为卤素, Pl、 P3定义如上所述定义; Wherein: X is a halogen, and P1 and P3 are defined as defined above;
i. 式 15所示化合物关环得到式 5所示化合物。 i. The compound of formula 15 is ring-closed to give the compound of formula 5.
4, 化合物 1还可通过下述方法制备,  4. Compound 1 can also be prepared by the following method.
与氨基保护拭剂反应得到式 33所示化合物 ,
Figure imgf000008_0002
其中: P1如上所述定义;
Reacting with an amino-protective detergent to give a compound of formula 33,
Figure imgf000008_0002
Where: P1 is defined as described above;
化合物通过 Mitsunobu反应后水解, 得到式 32所示化合物,  The compound is hydrolyzed by a Mitsunobu reaction to give a compound of the formula 32.
化合物羟基保护得到式 31所示化合物 ,
Figure imgf000008_0003
Hydroxy protection of the compound gives the compound of formula 31,
Figure imgf000008_0003
PI, P2如上所述定义;  PI, P2 are defined as described above;
合物与羧基保护试剂反应得到式 30所示化合物,
Figure imgf000008_0004
其中: R P P2如上所述定义;
The compound is reacted with a carboxy protecting reagent to give a compound of the formula 30,
Figure imgf000008_0004
Where: RP P2 is defined as described above;
e. 式 30所示化合物在氧化得到式 29所示化合物,
Figure imgf000009_0001
e. The compound of formula 30 is oxidized to give a compound of formula 29,
Figure imgf000009_0001
28  28
其中: Rl, PI, P2, 如上所述定义;  Where: Rl, PI, P2, as defined above;
f. 式 29所示化合物水解或醇解得到式 28所示化合物,
Figure imgf000009_0002
f. Hydrolysis or alcoholysis of the compound of Formula 29 to give a compound of Formula 28,
Figure imgf000009_0002
28  28
其中: R2为氢、有机金属离子如钠、 權、 钾离子以及'掠基、 芳烷基、 芳环 上被取代的芳烷基, Rl、 Pl、 Ρ2如上所述定义;  Wherein: R2 is hydrogen, an organometallic ion such as sodium, a weight, a potassium ion, and a 'grac group, an aralkyl group, an substituted aralkyl group on the aromatic ring, and R1, P1, and Ρ2 are as defined above;
g. 式 28所示化合物还原得到式 27所示化合物,
Figure imgf000009_0003
g. Reduction of the compound of formula 28 to give a compound of formula 27,
Figure imgf000009_0003
27  27
其中: Rl、 Pl、 P2、 P3如上所 ¾定义; Where: Rl, Pl, P2, P3 are defined as above;
h. 式 27所示化合物与 Wittig试剂反应得到式 26所示化合物 '
Figure imgf000009_0004
h. Compound of formula 27 is reacted with Wittig reagent to give compound of formula 26'
Figure imgf000009_0004
26  26
其中: Rl、 PI, P2、 P3如上所述定义; Where: Rl, PI, P2, P3 are defined as described above;
i. 式 26所示化合物还原得到式 25所示化合物,
Figure imgf000009_0005
i. Reduction of the compound of formula 26 to give a compound of formula 25,
Figure imgf000009_0005
其中: Pl、 P2、 P3如上所述定义; Where: Pl, P2, P3 are defined as described above;
j. 式 25所示化合物与 Bestmann-oMra试剂反应得到式 24所示化合物, OP2 NP3P1 j. The compound of formula 25 is reacted with a Bestmann-oMra reagent to give a compound of formula 24, OP 2 NP 3 P 1
24  twenty four
其中: PI, P2、 P3如上所述定义; Where: PI, P2, P3 are defined as described above;
k, 式 24所示化合物氧化得到式 2所示化合物。 k, the compound of the formula 24 is oxidized to give a compound of the formula 2.
Figure imgf000010_0001
.
Figure imgf000010_0001
6. 式 2所示化合物,  6. a compound of formula 2,
Figure imgf000010_0002
Figure imgf000010_0002
其中: 环氧立体构型可为 R-构型, S-构型或 R,S-构型 。 Wherein: the epoxy stereo configuration can be R-configuration, S-configuration or R, S-configuration.
为了更好的理解本发明,以下将通过具体的实例进行详细的阐述,应该说明的是, 以下实倒并非是对本发明范围的限制,显然,本领域的普通技术人员可以根据本 文说明,在本发明范围内对本发明做出各种各样的修正和改变,这些修正和改变 也翁入本发明的范围。 In order to better understand the present invention, the following detailed description of the present invention will be understood by the following examples. It should be understood that the following description is not intended to limit the scope of the invention. Various modifications and changes of the present invention are possible within the scope of the invention.
实例 1 (化合物 13a的合成, m=I¾) Example 1 (synthesis of compound 13a, m = I3⁄4)
Figure imgf000010_0003
Figure imgf000010_0003
倫 13a  13a
氮气保护下,在 3000niL反应瓶中加入苯甲醛 (200g, 1887mmol, 8.3eq), 电 动搅拌加入无水氯化 #(50g, 6.8mmol, l,62eq), 加入 N-乙酰 -D-氣基葡萄糖 14a(50g, 226mmol, leq), 20-40Ό反应 18小时后, HPLC中控, 14a小于 1%, 停止反应, 加入 740g乙酸乙酯打浆 2小时后, 过滤, 滤饼大量乙酸乙酯洗涤, 鼓风千燥 6小时得 1½白色固体 60g, 收率 86%。  Under nitrogen protection, benzaldehyde (200g, 1887mmol, 8.3eq) was added to the 3000niL reaction flask, and anhydrous chlorination # (50g, 6.8mmol, l, 62eq) was added by electric stirring, and N-acetyl-D-gas-based glucose was added. 14a (50g, 226mmol, leq), 20-40Ό reaction for 18 hours, HPLC control, 14a less than 1%, stop the reaction, add 740g of ethyl acetate for 2 hours, filter, filter cake, a large amount of ethyl acetate wash, drum The wind was dried for 6 hours to obtain 11⁄2 white solid 60g, yield 86%.
实倒 2 (化合物 13a的合成, Rl=Ph) 氮气保护下,在 3000mL反应瓶中加入苯甲醛 (200g, 1887mmol, 8.3eq), 电 动搅拌加入无水对甲苯磺酸一水合物 (0.45g, 2,26mmol, O.Oleq),加入 N-乙酰 -D- 氨基葡萄糖 Ma(50g, 226imnol, leq), 204CTC反应 18小时后, HPLC中控, 14a 小于 1%, 停止反应, 加入 740g乙酸乙酯 65'C打浆 6小时后, 过滤, 滤饼大量 乙酸乙酯洗涤, 鼓风千燦 6小时得 13a白色固体 55g, 收率 78.6«½。 Really inverted 2 (synthesis of compound 13a, Rl=Ph) Under nitrogen protection, benzaldehyde (200 g, 1887 mmol, 8.3 eq) was added to a 3000 mL reaction flask, and anhydrous p-toluenesulfonic acid monohydrate (0.45 g, 2,26 mmol, O.Oleq) was added by electric stirring, and N-acetyl was added. -D- Glucosamine Ma (50g, 226imnol, leq), After reacting with 204CTC for 18 hours, HPLC control, 14a less than 1%, stop the reaction, add 740g of ethyl acetate 65'C for 6 hours, filter, filter, a large amount of filter cake The mixture was washed with ethyl acetate, and pulverized for 6 hours to obtain a white solid of 55 g of a white solid, yield 78.6 «1⁄2.
实例 3 (化合物 1 的合成, Rl=Ph, P2=P4=Ac) Example 3 (synthesis of compound 1, Rl=Ph, P2=P4=Ac)
Figure imgf000011_0001
Figure imgf000011_0001
在 1L反应瓶中加入 13a( 50g, 161.7mmol, leq), 吡啶( 680g, 8597mmol» 53eq), 加毕, 滴加醋酸酐 (320g, 3134,4mol, 19.4eq), 控制温度 20-30°C, 滴加 毕, 升温至 40-45 °C反应 10小时, HPLC中控 13a小于 1%, 控制温度 60°C以下 减压蒸馏溶剂吡啶,蒸至体系粘 ffi,停止蒸馏,降温至 15-25Ό ,加 340g甲叔醚, 搅抨 5小时, 过滤, 鼓风千燥得 55.9g白的固体 12a, 收率 89%。 Add 13a (50g, 161.7mmol, leq), pyridine (680g, 8597mmol» 53eq) to a 1L reaction vial, add dropwise, add acetic anhydride (320g, 3134, 4mol, 19.4eq), control temperature 20-30 °C After the dropwise addition, the temperature is raised to 40-45 ° C for 10 hours, the HPLC control 13a is less than 1%, the controlled temperature is below 60 ° C, the solvent pyridine is distilled under reduced pressure, steamed to the system ffi, the distillation is stopped, and the temperature is lowered to 15-25 Ό. Add 340 g of tert-ether ether, stir for 5 hours, filter, and blast dry to obtain 55.9 g of white solid 12a, yield 89%.
实例 4 (化合物 12b的合成, l=P , P2=P4=PhCO) Example 4 (synthesis of compound 12b, l=P, P2=P4=PhCO)
在 1L反应瓶中加入 13a( 50g, 161.7mmol» leq), 吡啶(680g, 8597mmol» 53eq), 加毕, 滴加苯甲酰氣 226g, 1608mmol, 10eq), 控制温度 20- 3(TC , 滴加 毕, 升温至 40-45 °C反应 10小时, HPLC中控 13a小于 1%, 控制温度《TC以下 减压蒸馏溶剂吡啶, 蒸至体系粘稠, 停止蒸馏降温至 15-25 °C, 加 34(¾甲叙醚, 搅拌 5小时, 过滤, 鼓风千燥得 70g白的固体 12b, 收率 83.6%。  Add 13a (50g, 161.7mmol» leq), pyridine (680g, 8597mmol» 53eq) to a 1L reaction flask, add benzoyl gas 226g, 1608mmol, 10eq), control temperature 20-3 (TC, drop) After the addition, the temperature is raised to 40-45 °C for 10 hours, the HPLC control 13a is less than 1%, the temperature is controlled below TC, the solvent pyridine is distilled under reduced pressure, steamed to a thick system, and the distillation is stopped to cool to 15-25 °C. 34 (3⁄4 methyl ether), stirred for 5 hours, filtered, blasted to dry 70 g of white solid 12b, yield 83.6%.
实例 5 (化合物 11a的合成, Rl=Ph, P4=Ac) Example 5 (Synthesis of Compound 11a, Rl = Ph, P4 = Ac)
Figure imgf000011_0002
在 IL反应瓶中加入无水甲醇 112g,控制温度低于 3(TC通氨气 2小时后待用; 氮气保护下,在 1L反应瓶中加入 12a( 55.9 g, 142.1mmol, leq),加入 THF 400g, 启动搅拌降温至 40-45'C , 开始 »加氨的甲醇溶液, 大约 1小时滴毕, 控制温度 反应 6.5小时后取样中控, 直到中间体转化完全, 控制温度 50'C以下, 开始浓缩溶剂, 加入 900g乙酸乙酯打浆 2小时, 过滤, 滤饼大量水洗, 70°C鼓 风千燥 12小吋, 的白色固体 lla 39.8g, 收率 79.2%。
Figure imgf000011_0002
Add 112g of anhydrous methanol to the IL reaction bottle, and control the temperature to be lower than 3 (TC is used for 2 hours after ammonia gas is used; Under nitrogen protection, add 12a (55.9 g, 142.1mmol, leq) to a 1L reaction flask, add 400g of THF, start stirring and cool down to 40-45'C, start » ammonia solution in methanol, drip for about 1 hour, control After 6.5 hours of temperature reaction, the sample was continuously controlled until the intermediate conversion was complete, the temperature was controlled below 50 ° C, the solvent was concentrated, and 900 g of ethyl acetate was added for 2 hours, filtered, and the filter cake was washed with plenty of water, and the temperature was 70 ° C. Osmium, a white solid lla 39.8 g, yield 79.2%.
实倒 6 (化合物 lib的合成, Ml=Ph, P4=PhCO) 在 1L反应瓶中加入无水甲醇 112g,控制温度低于 30'C通氣气 2小时后待用; 氮气保护下,在 1L反应瓶中加入 12b( 55.9 g, 142.1mmol, leq),加入 THF 400g, 启动 β拌降温至 40-45Ό , 开始瀹加氨的甲醇溶液, 大约 1小时 »毕, 控制温度 4045Ό反应 6.5小时后取样中控》 直到中间-体转化完全, 控制温度 50'C以下, 开始浓縮溶剂, 加入 900g乙酸乙酯打浆 2小时, 过滤, 滤饼大量水洗, 70°C鼓 风千燥 12小时, 的白色固体 Ub 42.0g, 收率 84.1% Really pour 6 (synthesis of compound lib, Ml=Ph, P4=PhCO) Add 112g of anhydrous methanol to the 1L reaction flask, control the temperature below 30'C for 2 hours, wait for use; under nitrogen protection, in 1L reaction Add 12b (55.9 g, 142.1mmol, leq) to the bottle, add 400g of THF, start the β mix and cool down to 40-45Ό, start to add ammonia solution in methanol, about 1 hour»Bi, control temperature 4045Ό reaction 6.5 hours after sampling Control until the intermediate-body transformation is complete, control the temperature below 50'C, start to concentrate the solvent, add 900g of ethyl acetate for 2 hours, filter, filter cake washed with plenty of water, blast at 70 ° C for 12 hours, white solid Ub 42.0g, yield 84.1%
实倒 7 (化合物 10a的合虑, Rl=Ph) Really inverted 7 (consideration of compound 10a, Rl=Ph)
Figure imgf000012_0001
Figure imgf000012_0001
氮气保护下, 在 1L反应瓶中加入 lla( 40 g, 113,8mmol, leq), 二甲亚 ϊ凤 281.5g( 降温至 20-25'C , 快速滴加醋酸酐( 60.7g, 59.46mmol, 5,5eq), 30分钟 漓加毕,控制在该温度反应 16小时, 取样 HPLC中控至 11a小于 1%,将反应液 清加到 500mL冰水中, 搅并 1小时, 过滤, 产品 70'C鼓风千燥 10小时得 10a 白色面体 30g, 收率 91%。 Under nitrogen protection, add 1a (40 g, 113,8 mmol, leq) to a 1 L reaction flask, and add 281.5 g of dimethyl sulfoxide ( cooling to 20-25'C, and quickly add acetic anhydride (60.7 g, 59.46 mmol, 5,5 eq), 30 minutes 漓 add, control at this temperature for 16 hours, sample HPLC controlled to 11a less than 1%, the reaction solution was added to 500mL ice water, stirred for 1 hour, filtered, product 70'C The blast was dried for 10 hours to obtain 10 g of white body 30 g, and the yield was 91%.
实例 8 (化合物 10a的合成, Rl=Ph) Example 8 (Synthesis of Compound 10a, Rl=Ph)
氮气保护下,在 1L反应瓶中加入 llb《40 g, 96.7mmol» leq),二甲亚砜 281.5g, 降温至 20- 25Ό , 快速滴加醋酸酐( 60.7g, 594,57mmol, 6, leq), 30分钟瀹加毕, 控制在该温度反应 16小时, 取祥 HPLC中控至 l ib小于 1%, 将反应液滴加到 500mL冰水中, 搅拌 1小吋, 过滤, 产品 70Ό鼓风千燥 10小时得 10a白色固体 25g, 收率 89%。 实例 9 (化合物 9a的合成, l=Ph)
Figure imgf000013_0001
Under nitrogen protection, add llb "40 g, 96.7mmol» leq), dimethyl sulfoxide 281.5g, and cool down to 20-25 1 in a 1L reaction flask, and quickly add acetic anhydride (60.7g, 594, 57mmol, 6, leq) ), after 30 minutes, the reaction was controlled at this temperature for 16 hours, and the HPLC was controlled to l ib less than 1%. The reaction droplets were added to 500 mL of ice water, stirred for 1 hour, filtered, and the product was 70 Torr. After drying for 10 hours, 10 g of a white solid of 25 g was obtained, yield 89%. Example 9 (synthesis of compound 9a, l = Ph)
Figure imgf000013_0001
«a ia  «a ia
在 1L加氢釜中,加入 10a( 30g, 103.7mmol» leq)粗品,加入溶剂甲醇 600g, 开.启 S拌后加入 10«%钯碳 5.3g, 氮气置换 3次, 氳气置换三次, 常压加氢反应 5 小时后, 取样 HPLC中控 10a小于 3%, 停止反应, 冷却到 15°C , 过滤, 滤液减 压浓缩到大量固体析出后过滤, 滤饼千燥, 得¾白的固体 28g, 收率 93%。 实例 W (化合物 9a的合成, R1=I¾)  In a 1L hydrogenation tank, add 10a (30g, 103.7mmol»leq) crude product, add 600g of solvent methanol, open and start S mix, add 10«% palladium carbon 5.3g, replace nitrogen three times, helium gas replacement three times, often After 5 hours of pressure hydrogenation reaction, the sampled HPLC controlled 10a was less than 3%, the reaction was stopped, cooled to 15 ° C, filtered, and the filtrate was concentrated under reduced pressure until a large amount of solid was precipitated and then filtered, and the filter cake was dried to obtain a solid of 28 g of white solid. , yield 93%. Example W (synthesis of compound 9a, R1 = I3⁄4)
在 1L加氢釜中,加入 10a( 30g, 103.7mmol, leq)粗品,加入溶剂甲醇 600g, 开启搅拌后加入 10%铂碳 5.3g, 氮气置换 3次, 氢气置换三次, 常压加氢反应 5 小时后, 取样 HPLC中控 10a小于 3%, 停止反应, 冷却到 15°C , 过滤, 滤液减 压浓缩到大量固体析出后过滤, 滅饼千燥, 得 ¾白的固体 25g, 收率 82.7%。 实倒 11 (化合物 8a的合成, Acid=HCl)  In a 1 L hydrogenation reactor, 10a (30g, 103.7mmol, leq) crude product was added, 600g of solvent methanol was added, and after stirring, 5.3g of 10% platinum carbon was added, 3 times of nitrogen substitution, three times of hydrogen replacement, atmospheric pressure hydrogenation reaction 5 After the hour, the sampled HPLC controlled 10a was less than 3%, the reaction was stopped, cooled to 15 ° C, filtered, and the filtrate was concentrated under reduced pressure until a large amount of solid was precipitated and then filtered, and the cake was dried to obtain a solid of 25 g of a white solid, yield 82.7%. . Really inverted 11 (synthesis of compound 8a, Acid = HCl)
Figure imgf000013_0002
Figure imgf000013_0002
da la  Da la
在 1L反应瓶中, 加入 9a ( 50g, ] 71.6mmol , leq), 加入 IN盐酸 50mL, 升 温 反应 2,5小时后 , HPLC中控 9a小于 1%,降温至 10'C后加入 2 X 250mL 二氯甲烷萃取, 水层蒸千得油状物自然冷却固化得 8a白色固体 Bg, 收率 97%。 实例 12 (化合物 7a的合成, PI=H, P3=Boc)  In a 1L reaction flask, add 9a (50g, ] 71.6mmol, leq), add 50mL of IN hydrochloric acid, and heat up the reaction for 2, 5 hours, HPLC control 9a less than 1%, cool down to 10'C and add 2 X 250mL The methyl chloride was extracted, and the water layer was steamed to obtain an oil which was naturally cooled and solidified to give a white solid Bg (yield: 97%). Example 12 (synthesis of compound 7a, PI = H, P3 = Boc)
Figure imgf000013_0003
在 1L反应瓶中加入 8a ( 50g, 253mmol, leq),甲醇 500mL,控制温度 10-15 °C 用三乙胺 (305.7g, 303.5 mmol, 1.2eq)调 pH至 9,维持在该温度范围滴加 (Boc)20 (66,4g, 303.5mmol, 1.2eq),加毕,控制温度 20-25'C反应 14小时后取样 HPLC 中控 8a小于 3%, 加入 200g乙酸乙酯提取后, 浓缩至 lOOmL结晶, 得 60g白色 结晶状固体' 7a, 收率 90%。
Figure imgf000013_0003
Add 8a (50g, 253mmol, leq), methanol 500mL, control temperature 10-15 °C, adjust the pH to 9 with triethylamine (305.7g, 303.5mmol, 1.2eq), maintain the temperature range Add (Boc) 2 0 (66,4g, 303.5mmol, 1.2eq), add, control temperature 20-25'C reaction for 14 hours, sample HPLC control 8a less than 3%, add 200g ethyl acetate extract, concentrate Crystallization to 100 mL yielded 60 g of a white crystalline solid '7a, yield 90%.
实倒 13 (化合物 7b的合成, P1=H, P3=Cbz) Really inverted 13 (synthesis of compound 7b, P1=H, P3=Cbz)
在 1L反应瓶中加入 8a ( 50g, 253ramol, leq),甲醇 500mL,控制温度 10-15 °C 用三乙胺 (305.7g, 303.5 mmol, 1.2εφ调 pH至 9, 维持在该温度范圈滴氯甲酸苄 酯 (51.8g, 303.65mmol, 1.2eq), 加毕, 控制温度 20-25'C反应 14小时后取样 HPLC中控 8a小于 3%,加入 200g乙酸乙酸提取后,浓缩至 WOmL结晶,得 65g 白色结晶状固体 7b, 收率 87%。  Add 8a (50g, 253ramol, leq), methanol 500mL, control temperature 10-15 °C, adjust the pH to 9 with triethylamine (305.7g, 303.5mmol, 1.2εφ, maintain the temperature in this temperature range) Benzyl chloroformate (51.8g, 303.65mmol, 1.2eq), after adding, control temperature 20-25'C reaction for 14 hours, sample HPLC controlled 8a less than 3%, add 200g acetic acid acetic acid extraction, and concentrate to WOmL crystal, 65 g of a white crystalline solid 7b was obtained in a yield of 87%.
实例 14化合物 6a的合成(R2= , P1=H, P3=Boc) Example 14 Synthesis of Compound 6a (R2=, P1=H, P3=Boc)
Figure imgf000014_0001
Figure imgf000014_0001
7a ia  7a ia
在 250mL反应瓶中加入 7a( 9.9g, 37,89mmol, leq), 78.5g吡啶搅拌溶解, 降温至 0- 5Ό , 滴加对甲苯磺酰氯的二氣甲烷溶液 (28.2g, 37.?7mmol, leq), 45分钟后滴加结束, 维持在该温度范围反应 2.5小时取样 HPLC中控无 7a, 加 入 200mL冰水中, 分液、 有机相无水硫酸镁千燥, 减压浓缩溶剂至无馏分, 外 温低于 得 6a无色油状物 13g, 收率 82%。  7a (9.9g, 37,89mmol, leq) was added to a 250mL reaction flask, 78.5g of pyridine was stirred and dissolved, and the temperature was lowered to 0-5Ό, and a di-methane solution of p-toluenesulfonyl chloride was added dropwise (28.2g, 37.?7mmol, Leq), after 45 minutes, the addition was completed, and the reaction was maintained at this temperature range for 2.5 hours. The HPLC was controlled without 7a, added to 200 mL of ice water, separated, and the organic phase was dried over anhydrous magnesium sulfate, and the solvent was concentrated under reduced pressure to a fraction. The external temperature was lower than that of 6 g of a colorless oil of 13 g, and the yield was 82%.
实钶 15化合物 6b的合成 (R2=Ms, P1=H, P3=Boc) 在 250mL反应瓶中加入 7a( 10g, 37.8 mmol, leq), 78.5g ¾t啶搅拌溶解, 降温至 0-5°C , 滴加甲磺酰氯的二氯甲烷溶液(28.'2g, 37,77mmol, leq) , 45分 钟后滴加结束,维持在该温度范围反应 2.5小时取样 HPLC中控无 7a,加入 200mL 冰水中,分液、有机相无水硫酸楼千燥,减压浓缩溶剂至无馏分,外温低子 6(TC , 得 6b无色油状物 10.2g, 收率 88.7%。 实例 16化合物 Sa的合成 ( P1=H, P3=Boc) Synthesis of compound 6b (R2=Ms, P1=H, P3=Boc) In a 250 mL reaction flask, 7a (10 g, 37.8 mmol, leq) was added, 78.5 g of 3⁄4tidine was stirred and dissolved, and the temperature was lowered to 0-5 °C. Add methanesulfonyl chloride in dichloromethane (28.'2g, 37,77mmol, leq), after 45 minutes, add dropwise, maintain the reaction in this temperature range for 2.5 hours, sample HPLC without 7a, add 200mL ice water The liquid and organic phase anhydrous sulphuric acid building is dry, the solvent is concentrated under reduced pressure until no fraction, and the external temperature is low (6, TC, 6b colorless oil 10.2g, yield 88.7%. Synthesis of Compound Sa of Example 16 (P1=H, P3=Boc)
Figure imgf000015_0001
Figure imgf000015_0001
在 250mL反应瓶中, 加入 6a(10g, 24mmol, leq), 甲醇 66g,碳酸钾 (11.7g, 61.37mmol, 2.5eq) (升温回流 2小时, HPLC中控原料无 6a, 过滤, 滤液浓缩 得固体 4.8g,固体加入 25mL饱和食盐水, 2 X 50mL乙酸乙酯萃取后浓缩得 3.8g, 固体用 lOmL乙酸乙酯结晶 5g白色固体 5a, 收率 85%  In a 250 mL reaction flask, 6a (10 g, 24 mmol, leq), 66 g of methanol, potassium carbonate (11.7 g, 61.37 mmol, 2.5 eq) was added. (The mixture was refluxed for 2 hours, and the material in the HPLC was free from 6a, filtered, and the filtrate was concentrated to give a solid. 4.8 g, solid was added to 25 mL of saturated brine, extracted with 2×50 mL of ethyl acetate and concentrated to give 3.8 g, and the solid was crystallized with 10 mL of ethyl acetate 5 g of white solid 5a, yield 85%
实例 17化合物 5a的合成( Pl=B P3=Boc) Example 17 Synthesis of Compound 5a (Pl=B P3=Boc)
在 250mL反应瓶中, 加入 6b(8.1g, 24mmol, leq), 二氯甲烷 66g, 甲薩 (5g, 89.2mmol, 3.0eq) (升温回流 2小时, HPLC中控原料无 6b, 过滤, 滤液浓 縮得固体 4.8g, 固体加入 25mL镇和食盐水, 2 X 50mL乙酸乙酯萃取后浓縮得 3.8g, 固体用 10mL乙酸乙酯结晶 6g白色固体 (5a), 收率 84%。  In a 250 mL reaction flask, 6b (8.1g, 24mmol, leq), 66g of dichloromethane, 66g (5g, 89.2mmol, 3.0eq) was added (the temperature was refluxed for 2 hours, the HPLC controlled material was not 6b, filtered, and the filtrate was concentrated. The solid was reduced to 4.8 g, and the solid was added to 25 mL of EtOAc (EtOAc), EtOAc (EtOAc)
实例 18化合物 4a的合成( P1=H, P3=Boc)
Figure imgf000015_0002
Synthesis of Compound 4a of Example 18 (P1=H, P3=Boc)
Figure imgf000015_0002
5a 4a  5a 4a
在 lOOmL反应瓶中加入 5a(1.3g, 5.34mmol, leq), THF 31g, 氣气保护下 降温至 -78'C, 开始滴加 25%二异丁基氣化铝(9.12g, ll,96mmol, 2.24eq), 滴 加毕, 控制在该温度反应 30分钟, TLC中控, 无 5a, 加入 20%酒石酸钾钠溶液 (25g, 17.72mmol, 3.3eq) 淬灭, 加入 30mL 甲叔醚缓慢升温至室温, 搅拌 1 小时后分液, 水相甲叔鍵萃取一次后合并, 饱和食盐水洗涤, 无水硫酸模千燥, 浓缩得产品 4a无色油状物 1 收率 92%直接用于下步反应。  5o (1.3g, 5.34mmol, leq), 31g of THF were added to the lOOmL reaction flask, the gas gas protection was lowered to -78'C, and 25% diisobutylaluminum hydride (12.12g, ll, 96mmol) was started to be added dropwise. , 2.24eq), after adding dropwise, control the reaction at this temperature for 30 minutes, control in TLC, without 5a, add 20% sodium potassium tartrate solution (25g, 17.72mmol, 3.3eq), quench, add 30mL of tert-butyl ether and slowly heat up After stirring for 1 hour, the mixture was separated, and the aqueous phase was extracted once with a tertiary bond. The mixture was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated to give product 4a as colorless oil. reaction.
实钶 19化合物 4a的合成( P1=H, P3=Boc) Synthesis of compound 19a (P1=H, P3=Boc)
在 5()0mL反应瓶中加入 5a(13g, 53.44mmol, leq), 甲醇 100g, 氮气保护 下降温至 20-25Ό , 开始硼氢化钠(2g » 52.81mmol» l.Oeq), 滴加毕, 控制在 该温度反应 30分钟, TLC中控,无 5a,加入 2N盐酸中和至 pH6-7,加入 150mL 甲叔醚萃取,搅拌 1小时后分液,水相甲叔醚萃取一次后合并,饱和食 ftzR洗涤, 无水硫酸領千燥, 浓缩得产品 4a无色油状物 llg, 收率 84%直接用于下步反应。 实例 20化合物 3a的合成( P1=H P3=Boc) 5a (13g, 53.44mmol, leq), 100g of methanol was added to a 5 () 0mL reaction flask, the temperature was lowered to 20-25 氮气 under nitrogen, and sodium borohydride (2g » 52.81mmol» l.Oeq) was started. control in The temperature was reacted for 30 minutes, controlled by TLC, without 5a, neutralized by adding 2N hydrochloric acid to pH 6-7, added with 150 mL of tert-ether ether, stirred for 1 hour, and then separated, and the aqueous phase was extracted once and then combined, and the saturated ftzR was added. Washing, anhydrous sulfuric acid collar dried, concentrated product 4a colorless oil llg, yield 84% directly used in the next step. Example 20 Synthesis of Compound 3a (P1 = H P3 = Boc)
Figure imgf000016_0001
氮气保护下, 在 KKtniL反应瓶中加入 4a C l,48gf 6.03 ol, leq), 11.8g 甲醇降温至 0-5°C, 加入 «酸钾 ( 1.66g, 12.03mmol, 2eq)后, 加入 (1-重氮基 -2- 氧代丙基)膦酸 (Bestmann-ohira试剂) (i.38g, ?.19mmol, 1.2eq), 自然升温至室 温反应 1小时, HPL C中控 4a小亍 3%, 过滤浓缩, 油状物过硅胶柱得 3a无色 油状物 1.2g, 收率 82%, 直接用于下歩反应。
Figure imgf000016_0001
Under nitrogen protection, add 4a C l, 48g f 6.03 ol, leq) to the KKtniL reaction flask, and 11.8g methanol was cooled to 0-5 ° C. After adding potassium acid ( 1.66g, 12.03mmol, 2eq), add ( 1-diazo-2-oxopropyl)phosphonic acid (Bestmann-ohira reagent) (i.38g, ?.19mmol, 1.2eq), naturally heated to room temperature for 1 hour, HPL C controlled 4a small 亍3 %, filtered and concentrated, the oil was passed through a silica gel column to give a 3a colorless oil, 1.2 g, yield 82%, directly used for the sputum reaction.
实倒 21化合物 2a的合成 C P1=H, P2=TBS, P3=Boc)
Figure imgf000016_0002
在 lOOmL反应瓶中加入 ¾ (0.76g, 3,15mmol, leq), 加入 6 Jg二氣甲烷溶 解后, 加入咪唑(0.64g, 9.4mmol, 3eq), 加毕缓慢 ¾加叔丁基二甲基氯硅烷的 二氣甲烷涪液 C2.95g, 6.3mmol, 2eq), 20-25 C反应 8小时后, HPLC中控 3a 反应完毕, 降温 10- 15'C加入 0.5N的盐酸搅拌 10分钟后分液, 有机相用饱和氯 化溶液洗涤, 无水疏酸镁千燥, 浓缩得 2a无色油状 » 0.7g, 收率 %, 直接用 亍下歩反应。
Synthesis of Compound 2a of P21; P P1=H, P2=TBS, P3=Boc)
Figure imgf000016_0002
Add 3⁄4 (0.76g, 3,15mmol, leq) to a 100mL reaction flask, add 6 Jg of di-methane to dissolve, add imidazole (0.64g, 9.4mmol, 3eq), add slowly 3⁄4 plus t-butyl dimethyl Chlorosilane di-nethane methane sputum C2.95g, 6.3mmol, 2eq), 20-25 C reaction 8 hours, HPLC control 3a reaction is completed, cooling 10-15'C added 0.5N hydrochloric acid for 10 minutes, then The organic phase is washed with a saturated chlorinated solution, anhydrous anhydrous magnesium sulfate is dried, and concentrated to give a colorless oil of <RTIgt;</RTI>
实 W 22化合物 la的合成 ( P1=H, P2=TBS, P3=Boc)
Figure imgf000017_0001
在 lOOmL的反应瓶中加入 THF 26,7g,二氯二茂钛( 1.05g, 4.22 mmol, 3eq)» 氮气置換 10分钟后,氮气保护下加入锌粉反应 1小时,反应温度 20-3(TC。在另 一 lOOmL反应瓶中加入 2a(0.5g, l,41mol, leq), 13.4gTHF氮气置换 10分钟后, 滴加已经准备好的一氯二茂钛 THF溶液,加毕,维持温度在 20-3CTC反应 3小时 后 HPLC中控, 原料 2a反应完毕, 减压蒸出 THF后, 加入 50mL甲叔醚降温至 10-15 加入 10%硫酸,搅拌 20分钟后分液,下层用 50mL甲叔醚萃取一次后, 有机相合并饱和食盐水洗添后无水硫酸镁干燥,浓缩得棕色油状物,直接过硅胶 柱得 la产品 0.45g, 收率 89%。 ¾ NMR CCDC13, MHz: 600): 6 =0.067-0.158
Synthesis of real W 22 compound la (P1=H, P2=TBS, P3=Boc)
Figure imgf000017_0001
THF 26,7 g, titanium dichlorotitanium oxide (1.05 g, 4.22 mmol, 3 eq)» was replaced in a 100 mL reaction flask for 10 minutes, and zinc powder was added for 1 hour under nitrogen protection. The reaction temperature was 20-3 (TC). Add 2a (0.5g, l, 41mol, leq) to another lOOmL reaction flask, and replace with 13.4g of THF nitrogen for 10 minutes, then add the prepared chlorotitanium tetrachloride THF solution, add and maintain the temperature at 20 After 3 hours of -3CTC reaction, the mixture was controlled by HPLC. The reaction of starting material 2a was completed. After distilling off THF under reduced pressure, 50 mL of tert-butyl ether was added to cool to 10-15, 10% sulfuric acid was added, and after stirring for 20 minutes, the mixture was separated, and the lower layer was treated with 50 mL of methyl tertiary ether. after extraction once with saturated brine and the organic phases were washed with water added over anhydrous magnesium sulfate and concentrated to give a brown oil which was directly la silica gel column to give the product 0.45g, yield 89% ¾ NMR CCDC1 3, MHz :. 600): 6 =0.067-0.158
(ra, 6H), 0.874-0.940(m, 9H,), 1.452 (s, 9H), 1,730-2.046 Cm, 2H), 2.544 (s, 1H), 3.215(s, 1H), 3,681-3.734(d, 2H), 4.201-4.234 Cm, 1H), 4.571-4.590(ra, 6H), 0.874-0.940 (m, 9H,), 1.452 (s, 9H), 1,730-2.046 Cm, 2H), 2.544 (s, 1H), 3.215(s, 1H), 3,681-3.734(d , 2H), 4.201-4.234 Cm, 1H), 4.571-4.590
(ra, 1H), 4.61(s, 1H), 5.056(s, IH), 5.197(s, 1H)。 (ra, 1H), 4.61 (s, 1H), 5.056 (s, IH), 5.197 (s, 1H).
实例 23化合物 la的合成( P1=H, P2=TBS, P3=Boc) 在 lOOmL的反应瓶中加入 THF 26,7g,二氯二茂钛( 1.05g, 4.22 mmol, 3eq)» 氫气置换 10分钟后,氮气保护下加入锰粉反应 1小时,反应温度 20-30'C。在另 一 lOOmL反应瓶中加入 2a(0.5g, 1.41mol, leq), 13.4gTHF氮气置换 10分钟后, 滴加已经准备好的一氯二茂钛 THF溶液,加毕,维持温度在 20-30'C反应 3小时 后 HPLC中控, 原料 2a反应完毕, 减压蒸出 THF后, 加入 50mL甲叔醚降温至 10-15 °C ,加入 10%»酸,搅拌 20分钟后分液,下层用 50mL甲叔醚萃取一次后, 有机相合并饱和食盐水洗添后无水硫酸镁干燥,浓缩得棕色油状物,直接过硅胶 柱得 la产品 0.42g, 收率 84%„ Example 23 Synthesis of compound la (P1 = H, P2 = TBS, P3 = Boc) In a 100 mL reaction flask was charged THF 26, 7 g, titanium dichlorotitanium oxide (1.05 g, 4.22 mmol, 3 eq) » Hydrogen displacement 10 After a minute, manganese powder was added under nitrogen for 1 hour, and the reaction temperature was 20-30'C. 2a (0.5g, 1.41mol, leq) was added to another 100mL reaction flask, and 13.4g of THF was replaced by nitrogen for 10 minutes. Then, the prepared chlorotitanium tetrachloride THF solution was added dropwise, and the temperature was maintained at 20-30. 'C reaction 3 hours, HPLC control, the raw material 2a reaction is completed, distilled off THF under reduced pressure, add 50mL of methyl tertiary ether to cool to 10-15 ° C, add 10%» acid, stir for 20 minutes, then separate the liquid, the lower layer After extracting 50 mL of methyl tertiary ether, the organic phase was combined with saturated brine and dried over anhydrous magnesium sulfate and evaporated.
1H MR (CD ¾, MHz; 600): δ =0.067-0.158 (m, 6H), 0,874-0.940(m, 9H,), 1.452(s, 9H), 1.730-2.046(m, 2H)» 2.544 (s» lH)» 3.215(s, IH), 3.681-3.734(d, 2H), 4.201-4,234 (m, IH), 4.571-4.590 Cm, 1H), 4,61(s, IH), 5,056(s, 1H), 5.197(s, 1H)。 实例 24化合物 lb的合成 <Pl= Boc, P2=TBS, P3=Boc) 1 H MR (CD 3⁄4, MHz; 600): δ = 0.067-0.158 (m, 6H), 0,874-0.940 (m, 9H,), 1.452 (s, 9H), 1.730-2.046(m, 2H)» 2.544 (s» lH)» 3.215(s, IH), 3.681-3.734(d, 2H), 4.201-4,234 (m, IH), 4.571-4.590 Cm, 1H), 4,61(s, IH), 5,056 ( s, 1H), 5.197(s, 1H). Example 24 Synthesis of Compound lb <Pl= Boc, P2=TBS, P3=Boc)
在 5()0iTiL的反应瓶中加入 THF lOOg,二氯二茂钛(8.3g, 33.34 mmol, 3eq), 氮气置换 10分钟后,氮气保护下加入锌粉反应 1小时,反应温度 20-3(TC。在另 一 500mL反应瓶中加入 2b(¾ 10.97 1 leq), lOOgTHF氮气置换 10分钟后, *加已经准备好的一氯二茂钛 THF溶液,加毕,维持温度在 20-30'C反应 3小时 后 HPLC中控, 原料 2b反应完毕, 减压蒸出 THF后, 加入 200mL甲叔醚降温 至 10-15Ό , 加入 10%¾酸, 搅拌 20分钟后分液, 下层用 2(K)n.L甲叔醚萃取一 次后,有机相合并饱和食盐水洗涤后无水硫酸镁千燥, 浓缩得棕色油状物, 直接 过硅胶柱得 1¾产品 4.0g, 收率 79.65%,  In a reaction flask of 5 () 0iTiL, THF 100 g, titanium dichloride (8.3 g, 33.34 mmol, 3 eq) was added, and after nitrogen substitution for 10 minutes, zinc powder was added under nitrogen for 1 hour, and the reaction temperature was 20-3 ( TC. Add 2b (3⁄4 10.97 1 leq) to another 500mL reaction flask, after replacing 100g of THF with nitrogen for 10 minutes, *add the prepared chlorotitanium tetrachloride THF solution, add it, keep the temperature at 20-30'C After 3 hours of reaction, the mixture was controlled by HPLC. After the reaction of the starting material 2b was completed, the THF was evaporated under reduced pressure. Then, 200 mL of tert-butyl ether was added to cool down to 10-15 Torr, 10% 3⁄4 acid was added, and the mixture was stirred for 20 minutes, and then separated, and the lower layer was used for 2 (K). After the extraction of the nL methyl tertiary ether, the organic phase was combined with saturated brine and washed with anhydrous magnesium sulfate, and then evaporated to give a brown oil, which was directly passed through a silica gel column to obtain a product of 4.0 g, yield of 79.65%.
¾ NMR (CDC13, MHz: 600): 6 =0.067-0,158 Cm, 6H), 0.874-0.940(m, 9H,), 1,452 (s, 腿), 1,730-2.046 (m, 2H), 2,544 (s, ffl), 3.215(s» ffl), 3.681-3.734(d, 2H), 4.201-4.234 (m, 1H), 4.571-4.590 (m, 1H), 4.61(s, 1H), 5.056(sf IH), 5, 197(s, IH)„ 3⁄4 NMR (CDC1 3 , MHz: 600): 6 = 0.067-0, 158 Cm, 6H), 0.874-0.940 (m, 9H,), 1,452 (s, leg), 1,730-2.046 (m, 2H), 2,544 (s , ffl), 3.215(s»ffl), 3.681-3.734(d, 2H), 4.201-4.234 (m, 1H), 4.571-4.590 (m, 1H), 4.61(s, 1H), 5.056(s f IH ), 5, 197(s, IH) „
= Boc, P2=TBS, P3=Boc)
Figure imgf000018_0001
在 500mL的反应瓶中加入 THF lOOg,二氯二茂钛(8.3g, 33,34 mmol, 3eq), 氮气置换 10分钟后,氮气保护下加入锌粉反应 1小时,反应温度 20-3(TC。在另 一 500mL反应瓶中加入 2c(5g, 10.97mol» Icq). lOOgTHF氮气置换 10分钟后, 漓加已经准备好的一氯二茂钛 THF溶液,加毕,维持温度在 20- 3(TC反应 3小时 后 HPLC中控, 原料 2b反应完毕, 减压蒸出 THF后, 加入 200mL甲叔醚降温 至 10-15Ό , 加入 10%硫酸, 搅拌 20分钟后分液, 下层用 2(K)mL甲叙醚萃取一 次后, 有机相合并饱和食盐水洗涤后无水硫酸镁干燥, *缩得棕色油状物,直接 过硅胶柱得 ib产品 4.2g, 收率 84%
= Boc, P2=TBS, P3=Boc)
Figure imgf000018_0001
In a 500 mL reaction flask, THF 100 g, titanium dichloride (8.3 g, 33, 34 mmol, 3 eq) was added, and after nitrogen substitution for 10 minutes, zinc powder was added under nitrogen for 1 hour, and the reaction temperature was 20-3 (TC). Add 2c (5g, 10.97mol»Icq) to another 500mL reaction flask. After 10 minutes of nitrogen replacement with lOOgTHF, add the prepared chlorotitanium tetrachloride THF solution and add it to maintain the temperature at 20-3 ( After TC reaction for 3 hours, HPLC was controlled. The reaction of starting material 2b was completed. After distilling off THF under reduced pressure, 200 mL of tert-butyl ether was added to cool down to 10-15 Torr, 10% sulfuric acid was added, and the mixture was stirred for 20 minutes, then separated, and the lower layer was used for 2 (K). After extracting once with mL of methyl sulphate, the organic phase was combined with saturated brine and washed with anhydrous magnesium sulfate, and then reduced to brown oil, and directly passed through silica gel column to obtain 4.2 g of ib product, yield 84%.
!H M (CDC13» MHz: 600): δ =0.067-0.158 (m» 6Η), 0.874-0.940(m, 9H,), 1.452 (s, 18H) , 1.730-2,046 Cm, 2H)» 2,544 (s, 1H), 3.215(s, 1H), 3.681-3,734(d, 2H)» 4.201-4,234 (ra, IH), 4.571-4,590 Cm, 1H), 4,61(s, IH), 5.056(s, 1H), 5.197(s, 1H)。 ! HM (CDC1 3 » MHz: 600): δ =0.067-0.158 (m» 6Η), 0.874-0.940(m, 9H,), 1.452 (s, 18H) , 1.730-2,046 Cm, 2H)» 2,544 (s , 1H), 3.215(s, 1H), 3.681-3,734(d, 2H)» 4.201-4,234 (ra, IH), 4.571-4,590 Cm, 1H), 4,61(s, IH), 5.056 (s, 1H), 5.197 (s, 1H).
实例 26化合物 lb的合成 (Pl= H» P2=TBS» P3=Boc)  Example 26 Synthesis of Compound lb (Pl = H» P2 = TBS » P3 = Boc)
Figure imgf000019_0001
Figure imgf000019_0001
M 1 a M 1 a
在 lOOmL的反应瓶中加入 THF 26.7g,二氯二茂钛(1.05g, 4.22 mmol, 3eq), 氮气置换 10分钟后,氮气保护下加入锌粉反应 1小时,反应温度 20-3(TC。在另 一 lOOmL反应瓶中加入 2d(0.5g, 1.41mol, leq), 13.4gTHF氮气置换 10分钟后, 滴加已经.准备好的一氯二茂钛 THF溶液,加毕,维持温度在 20-30'C反应 3小吋 后 HPLC中控, 原料 2a反应完毕, 减 Λ蒸出 THF后, 加入 50mL甲叙醚降温至 10-15 °C ,加入 10%硫蘭,搅拌 20分钟后分液,下层用 50raL甲叙醸萃取一次后, 有机相合并饱和食盐水洗》后无水硫酸镁千燥,浓缩得棕色油状物,直接过硅胶 柱得 la产品 0.44g, 收率 87% ¾ MR (CDC13, MHz: 600): 6 =0.067-0.158In a 100 mL reaction flask, 26.7 g of THF, titanium dichloride (1.05 g, 4.22 mmol, 3 eq) was added, and after nitrogen substitution for 10 minutes, zinc powder was added under nitrogen for 1 hour, and the reaction temperature was 20-3 (TC). After adding 2d (0.5g, 1.41mol, leq) to another lOOmL reaction bottle and replacing it with 13.4g of THF nitrogen for 10 minutes, the prepared chlorotitanium tetrachloride THF solution was added dropwise, and the temperature was maintained at 20- 30'C reaction 3 hours, HPLC control, the raw material 2a reaction is completed, after distilling off the THF, add 50mL of methyl sulphate to cool to 10-15 °C, add 10% sulphate, stir for 20 minutes, then dispense. The lower layer was extracted once with 50 raL of thymidine, and the organic phase was combined with saturated brine. The dried magnesium sulfate was dried and concentrated to give a brown oil, which was directly passed through a silica gel column to obtain a product of 0.44 g, yield 87% 3⁄4 MR (CDC1 3 , MHz: 600): 6 =0.067-0.158
Cm, 6H) , 0.874-0,940(m, 9H,)f 1.452 (s, 9H) , 1.730-2.046 (m, 2H), 2,544 (s, 1H), 3.215(s, 1H), 3.681-3.734(d, 2H), 4.201-4.234 (m, 1H) , 4.571-4.590Cm, 6H) , 0.874-0,940(m, 9H,) f 1.452 (s, 9H) , 1.730-2.046 (m, 2H), 2,544 (s, 1H), 3.215(s, 1H), 3.681-3.734(d , 2H), 4.201-4.234 (m, 1H) , 4.571-4.590
(m» 1H), 4.61(s, 1H), 5.056(s, 1H) , 5, 197(s, 1H)。 (m» 1H), 4.61 (s, 1H), 5.056 (s, 1H), 5, 197 (s, 1H).
实例 27化合物 22a的合成(Rl=Ph) Example 27 Synthesis of Compound 22a (Rl=Ph)
H°-\ ― _ ^ 晒∞、 H °-\ ― _ ^ drying,
23i 22a  23i 22a
氮气保护下在 5L反庫瓶中加入 23a C 500g, 5.81 1, leq)加人二氯甲烷 1L吡啶(4«g, 5.81mol, leq),降温至 5Ό ,加入苯甲酰氯(736 g, 5.25 mmol, 0.9eq)溶于 1L二氯甲烷溶液, 维持温度低于 10°C反应 3小时,反应化合物自然 升温至室温反应 12小时, TLC中控苯甲酰氯反应完全,加入 1M硫酸 (3 X 600mL) 和 2 X 600mL水, 分液有机相浓缩至 900mL后加入乙醇 750mL冷却析出晶体后 过滤, 滤液浓缩得 519g橘红色油状物 22a, 收率 52% 实例 28化合物 21a的合成( M=Ph R2=Ms) Add 5a C 500g, 5.81 1, leq) to a 5L anti-bottle with nitrogen to add 1L of pyridine (4«g, 5.81mol, leq), cool down to 5Ό, add benzoyl chloride (736 g, 5.25) Methyl, 0.9 eq) dissolved in 1 L of dichloromethane solution, maintained at a temperature below 10 ° C for 3 hours, the reaction compound was naturally warmed to room temperature for 12 hours, TLC controlled benzoyl chloride was completely reacted, and 1 M sulfuric acid (3 X 600 mL) was added. And 2 X 600 mL of water, the organic phase was concentrated to 900 mL, and then 750 mL of ethanol was added to cool and precipitate crystals, which were filtered, and the filtrate was concentrated to obtain 519 g of orange-red oil 22a, yield 52%. Example 28 Synthesis of Compound 21a (M = Ph R2 = Ms)
Figure imgf000020_0001
Figure imgf000020_0001
氮气保护下, 在 5L反应瓶中加入 21a (278 g, 1.46mol leq), 二氯甲烷 2.1L, 降温至 0 C , 加入三乙胺(224mL, 1.61mol, 1.1 eq), 加入 4-甲氮基 )1比 啶 (4.45 g, 36 mmol, 0.025eq), 滴加甲磺酰氣 (125mL 1.61 mol. 1,1 eq) 溶于 lOOmL二氯甲烷的溶液, 維持温度低于 5Ό滴完, ¾毕, 维持温度在 O'C反 应 2小时, HPLC中控无 21a, 加入 1.5L水, 攬拌 5分钟后分液, 有 Λ层依次 1.5L饱和碳酸氢钠溶液、 1M盐酸 1.5L洗條, 无水硫酸镁千燥浓縮得 21a棕色 油状物 350g, 收率 90%  Under a nitrogen atmosphere, 21a (278 g, 1.46 mol leq), 2.1 L of dichloromethane were added to a 5 L reaction flask, cooled to 0 C, triethylamine (224 mL, 1.61 mol, 1.1 eq) was added, and 4-methylnitrobenzene was added. Base) 1 pyridine (4.45 g, 36 mmol, 0.025 eq), dropwise addition of methanesulfonyl gas (125 mL 1.61 mol. 1,1 eq) in 100 mL of dichloromethane, maintaining the temperature below 5 Ό, 3⁄4 After completion, the temperature was maintained at O'C for 2 hours, and there was no 21a in the HPLC. After adding 1.5L of water, the mixture was mixed for 5 minutes, and then separated. The layer was saturated with 1.5 L of saturated sodium hydrogencarbonate solution and 1 M of hydrochloric acid with 1.5 L of strip. Anhydrous magnesium sulfate was concentrated and concentrated to obtain a brown oil of 21 g (yield: 90%).
实倒 29化合物 20a的合成( Rl=Ph, X=Br) The synthesis of compound 20a (Rl=Ph, X=Br)
Figure imgf000020_0002
Figure imgf000020_0002
氮气保护下,在 3L反应瓶中加入 21a(345 g, 1.29mol, leq),加入丙酮 1.7L, 降温至 10'C , 维持温度低于 15'C滴加溴化锂(223 g 2.57 1, 2.0eq)加毕, 维持在该温度反应 1.5小吋, TLC中控无 2 la, 过滤, 滤液减压浓缩后加入 2L 乙酸乙酯, 2 水洗 无水硫酸镁干燥, 过滤浓缩得 20a棕色油状物 303g, 收率 0%0 Under nitrogen protection, 21a (345 g, 1.29mol, leq) was added to a 3L reaction flask, 1.7L of acetone was added, and the temperature was lowered to 10'C. The temperature was lower than 15'C and lithium bromide was added (223 g 2.57 1, 2.0 eq). After the addition, the reaction was maintained at this temperature for 1.5 hours, and the TLC was controlled without 2 la. After filtration, the filtrate was concentrated under reduced pressure, and then 2L ethyl acetate was added, and the mixture was washed with anhydrous magnesium sulfate and filtered to afford 303 g of 20a brown oil. Yield 0% 0
实例 30化合物 19a的合成( Rl=¾) Example 30 Synthesis of Compound 19a (Rl=3⁄4)
Figure imgf000020_0003
乙 K氨基丙二酸二乙酯(258g l.Wmol, leq),四氢呋喃 3L,叔丁醇钾(146 g, 1.30mol, 1.09eq),升温回流 1小吋,加入 5(M)mL四氢咲喃溶解解的 19a (300 g, l,19mol, l eq) 10分钟加毕, 回流反应 2.5小时, TLC中控 20a仍有剩余, 补加乙酰氨基丙二酸二乙酯( 100g 0.47mol, 0.39eq) 和菽丁醇鄉 C58g, 0.417mol, 0.39eq), 回流反应 10小时后 TLC中控无 20a, 降温至室温, 过滤, 滤液减压浓缩至 1L后,加入 2L乙酸乙酯, 0.1N盐酸 1L洗涤,加入 1L水洗涤, 有机相浓缩得 1¾棕色油状物 365g, 收率 79%, 直接用于下步反应。
Figure imgf000020_0003
Ethyl diethylaminoethyl malonate (258 g l. Wmol, leq), 3 L of tetrahydrofuran, potassium tert-butoxide (146 g, 1.30 mol, 1.09 eq), refluxed for 1 hour, and added 5 (M) mL of tetrahydrogen The 19a (300 g, l, 19 mol, l eq) dissolved in the sputum was added for 10 minutes, refluxed for 2.5 hours, and the remaining 20% of TLC was still added, supplemented with diethyl acetamidomalonate (100 g 0.47 mol, 0.39eq) and butanol C58g, 0.417mol, 0.39eq), after refluxing for 10 hours, no T2 in TLC, cooled to room temperature, filtered, concentrated under reduced pressure to 1L, then added 2L ethyl acetate, 0.1N 1 L of hydrochloric acid was washed, washed with 1 L of water, and the organic phase was concentrated to give 365 g of a brown oil (yield: 79%).
实例 31化合物 18a的合成 Example 31 Synthesis of Compound 18a
Figure imgf000021_0001
Figure imgf000021_0001
在 5L反应瓶中加入 1¾ (300 g, 0.77mol, leq), 乙醇 1.5L, 水 氢氧 化钠 C92.5g, 2.31 1, 3eq)加热回流 4小时后, TLC中控 19a无剩佘, 减压浓 缩乙醇, 浓缩毕加入 1L乙酸乙酯, 用浓盐酸调 pH至 3.5, 加热回流 24小时, 冷却,浓盐蒙调 H至 2.5,加入 1.5L乙酸乙酯萃取,水相用 45%氣氧化钠调 pH 至 6.0,减压浓缩,残渣加入 500mL甲醇打浆,过滤, 25g活性炭加入后升温 50Ό 搅拌 20分钟, 过滤, 滤液减压浓缩, 得 18a橘&:色油状物 149g收率 100% 实例 32化合物 1¾的合成 (P1=H, P3=Boc)  In a 5L reaction flask, 13⁄4 (300 g, 0.77 mol, leq), 1.5 L of ethanol, 1.5 g of water, sodium hydroxide (C22.5 g, 2.31 1, 3 eq) were heated and refluxed for 4 hours, and there was no residual hydrazine in the TLC. Concentrate the ethanol, concentrate 1 L of ethyl acetate, adjust the pH to 3.5 with concentrated hydrochloric acid, heat to reflux for 24 hours, cool, dilute the salt to H to 2.5, add 1.5 L of ethyl acetate, and use 45% sodium sulphate in the aqueous phase. Adjust pH to 6.0, concentrate under reduced pressure, add residue to 500 mL of methanol, filter, add 25 g of activated carbon, heat up 50 Torr, stir for 20 minutes, filter, and concentrate the filtrate under reduced pressure to give 18a orange & color oil 149g yield 100%. Synthesis of 13⁄4 (P1=H, P3=Boc)
Figure imgf000021_0002
在 5L反应瓶中加入 18a ( 125g, 0.67mol, leq), 30Mm KH2PO4 1.7L H7, 加入 L-乙難化酶 (200U/g底物) 室温至 6(TC维持 PH7反应直到 ^-NMR中控 显示转换率大于 40%, 降温至 20- 25 C , 加入 Boc20 (47 g, 0.27mol, 0.4eq) 溶于 200mL四 S呋喃溶液, 20-25'C反应,维持反应 pH 10直至不变,加入 5()0mL 甲叔醚, 加入硫酸氢钾调 pH至 3 , 加入乙酸乙酯 3 X 1L萃取, 有机相合并, 无 水硫酸養千燥, 过滤蒸千得 44g黄色油状物 17a' 收率 36%。
Figure imgf000021_0002
Add 18a (125g, 0.67mol, leq), 30Mm KH 2 PO 4 1.7L H7 to the 5L reaction flask, add L-ethylidene (200U/g substrate) to room temperature to 6 (TC maintain PH7 reaction until ^- NMR control showed a conversion rate of more than 40%, cooled to 20-25 C, added Boc 2 0 (47 g, 0.27 mol, 0.4 eq) dissolved in 200 mL of tetrasfuran solution, 20-25'C reaction, maintaining the reaction pH 10 Until the constant, add 5 () 0mL of tert-butyl ether, add potassium hydrogen sulfate to adjust the pH to 3, add ethyl acetate 3 X 1L extraction, organic phase combined, no The water sulfuric acid was dried and filtered, and the steam was obtained to obtain 44 g of a yellow oil 17a' yield of 36%.
=H, P3=B
Figure imgf000022_0001
=H, P3=B
Figure imgf000022_0001
在 2L加氢反应釜中加入 17a ( 30g, 0.162mol, leq), 加入 Lindlar催化 剂 3g, 氮气置换 3次后, 加氢至 lbar, 温度 20 ' HPLC中控 17a小于 1%, 泄 压后氮气置换, 过滤, 浓缩得 16a油状物 30g。  Add 17a (30g, 0.162mol, leq) to a 2L hydrogenation reactor, add 3g of Lindlar catalyst, replace it with nitrogen for 3 times, hydrogenate to lbar, temperature 20' HPLC control 17a less than 1%, nitrogen replacement after pressure relief Filtered and concentrated to give 30 g of 16a oil.
Figure imgf000022_0002
Figure imgf000022_0002
在 1L反应瓶中加入 16a (30 g, 0.162 mol, 1 eq), 300mL西氢呋喃, 瀹加 N-溴代丁二酰亚胺(31.71 g, 0.178mol, Ueq)温度 20-25 °C , 反应 30分钟, HPLC中控无 16a, 减压浓缩溶剂后, 加入 80mL乙酸乙酯和 120mL打浆 30分 钟, 过滤得产品 15a白色固体 29g收率 56%。  Add 16a (30 g, 0.162 mol, 1 eq), 300 mL of chlorohydrofuran, and add N-bromosuccinimide (31.71 g, 0.178 mol, Ueq) at a temperature of 20-25 °C in a 1 L reaction flask. The reaction was carried out for 30 minutes, and the mixture was controlled under HPLC for 16a. The solvent was concentrated under reduced pressure, and then ethyl acetate (100 mL) and 120 mL of hexanes were added for 30 minutes, and the product 15a was obtained as a white solid.
实倒 35化合物 5a的合成 (P1=H, P3=Boc)  Synthesis of compound 35a (P1=H, P3=Boc)
Figure imgf000022_0003
在 500mL反应瓶中加入 15a (29 g, 0.0895 mol, 1.0 eq), 甲醇 290mL, 碳 酸钾 (42.6 g, 0.223 mol, 2.5eq)升温回流 2小时, HPLC中控 15a, 过滤, 滤 液浓缩得产品 20g 白色固体 5a, 收率 92%。
Figure imgf000022_0003
15a (29 g, 0.0895 mol, 1.0 eq), 290 mL of methanol, potassium carbonate (42.6 g, 0.223 mol, 2.5 eq) was refluxed for 2 hours in a 500 mL reaction flask, 15a was filtered in HPLC, filtered, and the filtrate was concentrated to give 20 g. White solid 5a, yield 92%.
[0067] 实例 36 (化合物 33a的合成, Pl=Boc) Example 36 (Synthesis of Compound 33a, Pl = Boc)
Figure imgf000023_0001
在 2L反应瓶中加入 L-羟脯氨酸(60g, 457mmol, leq), 四氢呋喃 600mL, 水 300mL, 降温至 25-30'C滴加 10%的氣氧化钠 180mL,滴加(Boc) 20(135.8g, 622mmol, 1.36eq)滴毕, 维持在该温度反应 12小时后, HPLC中控无 L-羟脯胺 酸 10%硫酸氣钾溶液调 pH至 2.0-2.5之间, 2 X250mL乙酸乙酯萃取两次后浓 缩, 得 97.8g无色油状物 3¾, 收率 92.43%, 直接用于下歩反应。
Figure imgf000023_0001
Add L-hydroxyproline (60g, 457mmol, leq), tetrahydrofuran 600mL, water 300mL in a 2L reaction flask, cool down to 25-30'C, add 10% sodium oxide 180mL, add (Boc) 2 0 (135.8g, 622mmol, 1.36eq) was added, after maintaining the reaction at this temperature for 12 hours, the HPLC was controlled without L-hydroxyproline 10% potassium sulfate solution to adjust the pH to 2.0-2.5, 2 X250mL acetic acid The ester was extracted twice and concentrated to give 97.8 g of a colorless oil (yield: 92.43%).
实倒 37 (化合物 32a的合成, Pl=Boc)  Really inverted 37 (synthesis of compound 32a, Pl=Boc)
Figure imgf000023_0002
氮气保护下,在 2L反应瓶中加入 33a (94.2g, 407.35mmol, leq), 1250gTHF, 加入三苯基膦 C320g, 1222mmol, 3.0eq), 降温至 0- 5°C滴加偶氮二甲酸二异丙 酯(240g, llSOmmol, 2.9eq) 1小吋滴毕,控制温度 25- 30°C反应 3小时, HPLC 中控无原料 3¾剩余, 滴加碳酸氢钠溶液 (501.45g, 895.62mmol, 2.2eq)滴加结 束, 室温反应 8小时, HPLC中控中间体无剩余, 减压浓缩潜剂至无 THF后, 大量固体析出, 过滤, 滤饼用 2X 250mL水洗涤, 合并水相, 水相用冰醋酸调 H至 2.0-2.5之间,加入 2 X500mL乙酸乙酸萃取后,浓缩得 63.23g化合物 32a, 收率 67.1%, 直接用于下歩反应。
Figure imgf000023_0002
Under a nitrogen atmosphere, 33a (94.2g, 407.35mmol, leq), 1250g THF was added to a 2L reaction flask, triphenylphosphine C320g, 1222mmol, 3.0eq) was added, and the temperature was reduced to 0-5 °C and azodicarboxylic acid was added dropwise. Isopropyl ester (240g, llSOmmol, 2.9eq) 1 hour drop, control temperature 25- 30 ° C reaction for 3 hours, HPLC control no raw material left 33⁄4, add sodium bicarbonate solution (501.45g, 895.62mmol, 2.2 Eq) At the end of the dropwise addition, the reaction was carried out at room temperature for 8 hours. There was no residual intermediate in the HPLC. After decomposing the latent agent under reduced pressure to THF-free, a large amount of solid was precipitated, filtered, and the filter cake was washed with 2×250 mL of water, and the aqueous phase was combined. The glacial acetic acid was adjusted to a ratio of 2.0 to 2.5, extracted with 2 X 500 mL of acetic acid, and concentrated to obtain 63.23 g of compound 32a in a yield of 67.1%, which was directly used for the sputum reaction.
实例 38 (化合 ¾ 31a的合成, Pl=Boc, P2=TBS)  Example 38 (combination of compound 3⁄4 31a, Pl=Boc, P2=TBS)
Figure imgf000023_0003
Figure imgf000023_0003
32a 31a 在 2L反应瓶中加入 32a (36.30g, 157mmol, leq), 咪唑(53.43g, 785mmol, 4.½q)二氯甲烷 266g, 降温至 10-15'C , 滴加叔丁基二甲氯硅烷的二氯甲烷溶液32a 31a In a 2L reaction flask, add 32a (36.30g, 157mmol, leq), imidazole (53.43g, 785mmol, 4.1⁄2q) dichloromethane 266g, cool down to 10-15'C, add t-butyldimethylchlorosilane dropwise Dichloromethane solution
( 135g, l?3mmol, Ueq), 3小时加毕, 自然升温至 20- 25'C , 反应 10小时后, HPLC中控, 无 1¾无剩余, 滴加 0.5N ife酸调 pH至 2-2.5, 分液, 铯和氯化钠 溶液洗涤, 蒸千得 31a油状物 54g, W 99%, 直接用于下步反应。(135g, l?3mmol, Ueq), after 3 hours of addition, naturally warmed to 20-25 'C, after 10 hours of reaction, HPLC controlled, no 13⁄4 no residue, 0.5N ip acid added to adjust pH to 2-2.5 The liquid was separated, washed with hydrazine and sodium chloride solution, and steamed to obtain 54 g of oil as a 31a, W 99%, which was directly used for the next step.
, Rl=t-Bu)
Figure imgf000024_0001
, Rl=t-Bu)
Figure imgf000024_0001
31a 30a  31a 30a
在 500mL反应瓶中加入 3¼(58.8§,345.511111101, 1€9), 4-二甲氨基吡啶(4.16§, 34.0, 0.2eq), 148g叔丁醇降温至 10-15 °C ,滴加 (Boc )20的西氣呋喃溶液(225.8g, 425.43ramol, 2.5eq), 3小时后加毕, 升温至 20-25Ό反应 12小时后 HPLC中控 12a低于 2%, 减压蒸出叔丁醇和四氢呋喃后, 加入乙酸乙酯溶解, 饱和食盐水 洗搽,无水硫酸镁干燥,浓缩得 30a油状物 68g,收率 99%,直接用于下歩反应。In a 500 mL reaction flask, add 31⁄4 (58.8§,345.511111101,1€9), 4-dimethylaminopyridine (4.16§, 34.0, 0.2eq), 148g t-butanol to 10-15 °C, drop (Boc 2 0 of the West Gas Furan solution (225.8g, 425.43ramol, 2.5eq), after 3 hours, the temperature is raised to 20-25Ό, 12 hours after the reaction, the HPLC control 12a is less than 2%, and the t-butanol is distilled off under reduced pressure. After tetrahydrofuran, it was dissolved in ethyl acetate, washed with saturated brine, dried over anhydrous magnesium sulfate, and evaporated.
t-Bu)  t-Bu)
Figure imgf000024_0002
Figure imgf000024_0002
在 2L反应瓶中氮气保护下加入 30a(68.3g, 170.07 iol, leq), 1000g乙酸 乙酯, 纯化水 230g, 降温至 0°C , 加入 RuCl3.¾0 (10.8g, 41,3mmol, 0.24eq), 漓加高碘酸钠溶液 (66¾, 1550mmol, 9. leq), 3小时滴毕, 维持在 0-5°C反应 8 小时后, HPLC中控 30a小于 3%, 分液, 水相用 250mL甲叙醚取 1次后, 合并 有机相, 2X 250mL饱和食盐水洗绦, 无水硫酸镁干燥过滤,浓縮的 25.7g油状 物 29a。 30a (68.3g, 170.07 iol, leq), 1000g of ethyl acetate, 230g of purified water in a 2L reaction flask under nitrogen, cooled to 0 ° C, added RuCl 3 .3⁄40 (10.8g, 41,3mmol, 0.24eq ), adding sodium periodate solution (663⁄4, 1550mmol, 9. leq), after 3 hours of dropwise addition, maintaining the reaction at 0-5 ° C for 8 hours, HPLC controlled 30a less than 3%, liquid separation, aqueous phase After taking 250 mL of the methyl sulphate, the organic phase was combined, washed with 2×250 mL of brine, dried over anhydrous magnesium sulfate
实例 41 (化合物 28a的合成, Pl=Boc» P2=TBS» Rl=t-Bu» R2=Me)
Figure imgf000025_0001
在 1L反应瓶中加入 29a (30g, 72.18mmol, leq),加入 300g甲醇,降温至 O'C , 清加 25%的甲醇钠溶液(60g, 277.8 mmol, 3.84 eq), 加毕, 维持在该温度反应 2-3小时, HPLC中控无 2 , 0.5N的硫酸氢钾溶液调 pH至 6-7之间, 浓缩甲醇 后, 乙酸乙酯萃取, 千燥, 浓缩得 30g白色固体 a, 收率 92.8%。
Example 41 (Synthesis of Compound 28a, Pl=Boc» P2=TBS» Rl=t-Bu» R2=Me)
Figure imgf000025_0001
Add 29a (30g, 72.18mmol, leq) to a 1L reaction flask, add 300g of methanol, cool to O'C, add 25% sodium methoxide solution (60g, 277.8mmol, 3.84 eq), add, and maintain The temperature was reacted for 2-3 hours, and the HPLC was controlled without 2, 0.5N potassium hydrogen sulfate solution was adjusted to pH between 6 and 7. After concentration of methanol, ethyl acetate was extracted, dried, and concentrated to obtain 30 g of white solid a. 92.8%.
卖例 42 (化合物 28a的合成, Pl=Boc, P2=TBS, Rl=t-Bu, R2=Li) 在 1L反应瓶中加入 29a (30g, 72.18mmol» leq), 加入 300g四氢呋喃, 降 温至 0°C , 滴加氣氧化锂( 11.6g, 277.8 mmol, 3.84 eq), 加毕, 维持在该温度反 应 2-3小时, HPLC中控无 29a, 0.5N的硫酸氢钾溶液调 pH至 6-7之间, 浓缩 甲醇后, 乙酸乙酯萃取, 千燥, 浓缩得 28g白色固体 28a, 收率 85%。  Example 42 (Synthesis of Compound 28a, Pl = Boc, P2 = TBS, Rl = t-Bu, R2 = Li). In a 1 L reaction flask, 29a (30 g, 72.18 mmol» leq) was added, 300 g of tetrahydrofuran was added, and the temperature was lowered to 0. °C, add lithium oxide (11.6g, 277.8mmol, 3.84 eq), add and maintain at this temperature for 2-3 hours, HPLC control without 29a, 0.5N potassium hydrogen sulfate solution to adjust the pH to 6- After concentrating between methanol, ethyl acetate was extracted, dried, and concentrated to give 28 g of white solid 28a, yield 85%.
实例 43 (化合物 27a的合成, Pl= Boc, P2=TBS, P3=H, Rl=t-Bu, R2=Me)  Example 43 (Synthesis of Compound 27a, Pl = Boc, P2 = TBS, P3 = H, Rl = t-Bu, R2 = Me)
Figure imgf000025_0002
在 1L反应瓶中加入 28 a( 30 g» 67minol, leq), 西氢呋喃 300mL , 降温至 -78 , 滴加 25%二异丁基氢化铝 (38g, 6?mmol, 1.0 eq), 滴加结柬, 维持在该 温度反应 30分钟 HPLC中控 28a无剩余, 加入 10%酒石酸钾钠淬灭, 自然升温 至 20"C掘拌 1小时, 分液, 有机相饱和食盐水洗涤 2次, 无水硫酸镁千燥得 27a 无色油状物 23g, 收率 82%。
Figure imgf000025_0002
Add 28 a (30 g»67minol, leq) to a 1L reaction flask, 300 mL of THF, cool to -78, add 25% diisobutylaluminum hydride (38 g, 6 mmol, 1.0 eq) dropwise. The reaction was maintained at this temperature for 30 minutes. There was no residue in HPLC control 28a. It was quenched by adding 10% sodium potassium tartrate. The mixture was naturally warmed to 20 ° C for 1 hour, and the mixture was separated. The organic phase was washed twice with saturated brine. The water magnesium sulfate was dried to obtain 27 g of a colorless oil (yield: 82%).
实例 44 (化合物 26a的合成, Pl= Boc, P2=TBS, P3=H, M=t-Bu)
Figure imgf000026_0001
Example 44 (Synthesis of Compound 26a, Pl = Boc, P2 = TBS, P3 = H, M = t-Bu)
Figure imgf000026_0001
27* Aa 27* Aa
氮气保护下, 在 500mL反应瓶中加入叔丁醇钾(7g, 62.9mmol, 1.61 eq), 加入无水 l OOmL 四氢呋喃降温至 5-10'C , 加入甲基三苯基溴化麟( 23.6 g, 66.0mmol» 1.69eq), 自然升温至室温反应 1小时, 降温至 O-5'C , 加入 27a四氢 呋喃溶液 ( 70 g, 54.8mmol, l.Oeq)维持在该温度反应 1小时, HPLC中控无 27a, 过滤, 滤液浓缩, 加入 lOOmL甲叔醚溶解后, 降温至 10-15°C , 0.5醋酸调 pH 至 0-2, 分液, 有机相饱和氯化钠洗涤 2次, 无水硫酸镁千燥, 过滤浓缩得 26a 油状物 15.4g, 收率 94.9%。  Under a nitrogen atmosphere, potassium tert-butoxide (7 g, 62.9 mmol, 1.61 eq) was added to a 500 mL reaction flask, and anhydrous 100 mL of tetrahydrofuran was added to cool to 5-10 ° C, and methyltriphenyl bromide (23.6 g was added). , 66.0mmol» 1.69eq), naturally warmed to room temperature for 1 hour, cooled to O-5'C, added 27a tetrahydrofuran solution (70 g, 54.8 mmol, 1.0 eq) to maintain the reaction at this temperature for 1 hour, HPLC control No 27a, filtered, the filtrate was concentrated, dissolved in 100 mL of tert-butyl ether, cooled to 10-15 ° C, pH adjusted to 0-2 with 0.5 acetic acid, separated, washed twice with saturated organic sodium chloride, anhydrous magnesium sulfate After drying, it was concentrated by filtration to obtain 15.4 g of a 26a oil, yield 94.9%.
实倒 45 (化合物 26a的合成, Pl= Boc, P2=TBS, P3=H, Rl=t-Bu) 氮气保护下, 在 500mL反应瓶中加入氢化钠(1.51g» 62.9mmol» 1.61 eq), 加入无水 lOOmL 四氢呋喃降温至 5-1CTC , 加入甲基三苯基溴化 β( 23.6 g, 66.0mmol» 1.69eq), 自然升温至室温反应 1小时, 降温至 0- 5Ό , 加入 27a四氢 呋喃溶液(70 g, 54.8mmol, l.Oeq)维持在该温度反应 1小时, HPLC中控无 27a, 过滤, 滤液浓缩, 加入 lOOmL甲叔醚溶解后, 释温至 10-15Ό , 0.5醋酸调 pH 至 0-2, 分液, 有机相饱和氯化钠洗涤 2次, 无水硫酸镁千燥, 过滤浓缩得 26a 油状物 14.8g, 收率 91.0%。  Really pour 45 (synthesis of compound 26a, Pl = Boc, P2 = TBS, P3 = H, Rl = t-Bu). Under a nitrogen atmosphere, sodium hydride (1.51 g»62.9 mmol»1.61 eq) was added to a 500 mL reaction flask. Add anhydrous 100 mL of tetrahydrofuran to 5-1 CTC, add methyltriphenyl bromide β (23.6 g, 66.0 mmol» 1.69 eq), naturally warm to room temperature for 1 hour, cool to 0-5 Torr, add 27a tetrahydrofuran solution ( 70 g, 54.8 mmol, l.Oeq) maintained at this temperature for 1 hour, HPLC controlled without 27a, filtered, concentrated filtrate, dissolved in 100 mL of tert-butyl ether, released to 10-15 Ό, 0.5 acetic acid adjusted to pH 0 The mixture was washed twice with saturated sodium chloride and dried over anhydrous magnesium sulfate.
实倒 46 (化合物 26a的合 , Pl=Boc, P2=TBS» P3=H)
Figure imgf000026_0002
Really invert 46 (combination of compound 26a, Pl=Boc, P2=TBS» P3=H)
Figure imgf000026_0002
2«a 28a  2«a 28a
在 1L反应瓶中加入 26a(22g, 52.9mmol, leq), 530g四氢呋喃,降温至 -78Ό ' 清加 25%二异丁基氢化铝(60.4g, 106.2mmol , 2,0eq),加毕,控温 Sft在 -78°C 反应 30分钟, HPLC中控,无 26a,无水甲醇淬灭后,加入 10%酒石酸钾铀 200g, 逐渐升温至室温搅拌 1小时分液,有机相饱和氣化钠洗條 2次,无水硫酸镁干燥, 过滤, 浓缩得 25a无色油状物 1.8g, 收率 98.8%。 实例 47 (化合翁 24a的合成, Pl=Boc, P2=TBS, P3=H) In a 1 L reaction flask, add 26a (22g, 52.9mmol, leq), 530g of tetrahydrofuran, and cool down to -78Ό ' 25% diisobutylaluminum hydride (60.4g, 106.2mmol, 2,0eq), add, control The temperature Sft was reacted at -78 ° C for 30 minutes, controlled by HPLC, without 26a, after quenching with anhydrous methanol, adding 10% potassium uranium tartrate 200g, gradually warming to room temperature, stirring for 1 hour, liquid separation, organic phase saturated gasification sodium washing The mixture was dried twice with anhydrous magnesium sulfate, filtered and evaporated to ethylamine. Example 47 (Synthesis of Compound 24a, Pl=Boc, P2=TBS, P3=H)
Figure imgf000027_0001
Figure imgf000027_0001
25a 24a  25a 24a
在 500mL反应瓶中加入 25a(13.4g, 39mmol, leq),无水甲醇 158g, 降温至 5 'C , 加入无水碳酸钾(10.7g, 77.5mmol, 2eq), 滴加 (1-重氣基 -2-氧代丙基).麟 酸 (Bestmami- oMra试剂)(9.1g, 46,9mmol, 1.2eq), 滴加毕, 自然升温至 20-25°C 反应 1小吋 101^中控¾小于 5%, 过滤, 滤液 *缩得 24a油状物 12.5g, 收率 94%,  Add 25a (13.4g, 39mmol, leq) to a 500mL reaction flask, 158g of anhydrous methanol, cool down to 5 'C, add anhydrous potassium carbonate (10.7g, 77.5mmol, 2eq), add (1-heavy gas base) -2-Oxopropyl). Lintami (Osmami- oMra reagent) (9.1g, 46,9mmol, 1.2eq), added dropwise, naturally heated to 20-25 ° C reaction 1 hour 吋 101 ^ control 3⁄4 Less than 5%, filtered, filtrate * reduced to 24 g oil 12.5 g, yield 94%,
实例 48化合物 2a的合成, Pl=Boc, P2=TBS, P3=H)  Example 48 Synthesis of Compound 2a, Pl = Boc, P2 = TBS, P3 = H)
Figure imgf000027_0002
Figure imgf000027_0002
3a 2a  3a 2a
氮气保护下, 在 WOmL的反应瓶中加入间氯过氧苯甲酸 (4.8g, 29.6mmol, leq), 二氯甲垸 53g温度 20- 25'C , 搅拌溶解后加入 2a(10g, 29,5 mmol, leq)体 系无明显升温,维持在该温度范围反应 52小时后 TLC中控无 2a,饱和疆酸氣铀 洗涤,饱和氯化钠洗涤,硫酸镁干燥,过柱得产品 la无色油状物 10g,收率 95.5%, 直接用于下歩反应。 ¾ NMR CCDCta, MHz: 600): δ =0.071-0.179 (m, 6Η), 0.874-0.940(111, 9H)» 1.443-1.482 Cm, 9H), 1.786-1.997 (m, 2H), 2.281-2.292 (t, 1H), 2,561-2.974(1X1' 3H), 3.649-3.828(d, 1H), 4.575 (s, 1H), 5,294-5.473(d, 1H)  Under nitrogen protection, add m-chloroperoxybenzoic acid (4.8g, 29.6mmol, leq) to the reaction flask of WOmL, and dichloromethane 53g temperature 20-25 'C, stir and dissolve, then add 2a (10g, 29,5) The mmol, leq) system has no obvious temperature rise. After maintaining the temperature in this temperature range for 52 hours, there is no 2a in the TLC control, the saturated acid chloride is washed with uranium, the saturated sodium chloride is washed, the magnesium sulfate is dried, and the product is obtained as a colorless oil. 10 g, yield 95.5%, used directly in the sputum reaction. 3⁄4 NMR CCDCta, MHz: 600): δ = 0.071-0.179 (m, 6Η), 0.874-0.940 (111, 9H)» 1.443-1.482 Cm, 9H), 1.786-1.997 (m, 2H), 2.281-2.292 ( t, 1H), 2,561-2.974(1X1' 3H), 3.649-3.828(d, 1H), 4.575 (s, 1H), 5,294-5.473(d, 1H)

Claims

1. 1所示化合物的制备方法, 其特征在于:
Figure imgf000028_0001
A method for preparing a compound represented by 1. It is characterized in that:
Figure imgf000028_0001
以式 2所示化合物为原料, 在过渡金属^ 3中心的自由基条件下关环制备, 其中:  The compound represented by Formula 2 is used as a raw material, and is prepared by ring-closing under the free radical condition of the transition metal ^ 3 center, wherein:
PI , P3可以相同或不同, 分别代表氢、 烷氧基羰基或者芳烷氧基幾基;  PI and P3 may be the same or different and each represent a hydrogen, an alkoxycarbonyl group or an aralkoxy group;
P2选自 C1-6烷基, 卤代烷基、 ,基、 t- BuMe2Si、 t-BuPh2Si 、 Et3Si、 苯甲酸 基、 四氢吡喃 -2-基、 苯环上带有取代基的苯甲酰基、 联苯 -4-甲酰基; 式 2所示化合物环氧立体构型可为 R-构型, S-构型或 R,S-构型。 P2 is selected from C1-6 alkyl, haloalkyl, base, t- BuMe 2 Si, t- BuPh 2 Si, Et 3 Si, benzoyloxy, tetrahydropyran-2-yl, substituted on the phenyl ring with The benzoyl group and the biphenyl-4-formyl group; the epoxy stereo configuration of the compound of Formula 2 may be in the R-configuration, the S-configuration or the R, S-configuration.
2.权利要求 1所示的制备方法, 其特征在于: 所述的过渡金属为中心的自由基 为三价钛为中心的自由基。  The process according to claim 1, wherein the radical in which the transition metal is centered is a radical centered on trivalent titanium.
3.权利要求 1中所述化合物 2的制备方法, 其特征在于:  3. A process for the preparation of a compound 2 according to claim 1, characterized in that:
易斯酸催化下双径基保护制备式 13所示化合物,
Figure imgf000028_0002
Preparation of a compound of formula 13 by double-path base protection catalyzed by Lewis acid,
Figure imgf000028_0002
其中: R1为氢原子、 C1- 6垸基、 苯基或者带有取代基的苯基, 苯基上的取代基 优先选自甲氧基、 乙氧基、 卤素、 苯基和硝基; Wherein: R1 is a hydrogen atom, a C1-6 fluorenyl group, a phenyl group or a substituted phenyl group, and the substituent on the phenyl group is preferably selected from the group consisting of a methoxy group, an ethoxy group, a halogen group, a phenyl group and a nitro group;
性条件下反应得到式 12所示化合物,
Figure imgf000028_0003
The reaction is carried out under the conditions to obtain the compound of the formula 12,
Figure imgf000028_0003
其中: P4为酰基, R1如上所述定义; Wherein: P4 is an acyl group, and R1 is as defined above;
式 12所示化合物在 «性条件下,极性质子溶剂中选择性脱去羟基保护基 P4制备 Preparation of the compound of formula 12 under selective conditions, selective removal of the hydroxy protecting group P4 from the polar protic solvent
Figure imgf000028_0004
其中: Rl, P4如上所述定义;
Figure imgf000028_0004
Where: Rl, P4 are defined as described above;
式 11所示化合物在极性溶剂中通过氧化反应及消除反应得到式 10所示化合物,
Figure imgf000029_0001
The compound of the formula 11 is subjected to an oxidation reaction and a elimination reaction in a polar solvent to obtain a compound of the formula 10,
Figure imgf000029_0001
10  10
其中: R1如上所述定义; Where: R1 is defined as described above;
得到式 9所示化合物,
Figure imgf000029_0002
The compound of formula 9 is obtained,
Figure imgf000029_0002
8  8
其中: R1如上所述定义; Where: R1 is defined as described above;
性条件下得到式 8所示化合物的铵盐,  Obtaining the ammonium salt of the compound of formula 8 under the conditions of the reaction,
性条件下与氨基保护试剂反应得到式 7所示化合物,
Figure imgf000029_0003
Reaction with an amino protecting reagent under conditions to obtain a compound of formula 7,
Figure imgf000029_0003
其中: Pl、 P3如上所達定义; Where: Pl, P3 are as defined above;
基活化剂存在下得到式 6所示化合物,
Figure imgf000029_0004
a compound of formula 6 is obtained in the presence of a base activator,
Figure imgf000029_0004
其中: R2为甲磺酰基、 对甲苯磺酸基, Pl、 Ρ3如上所述定义; Wherein: R2 is a methylsulfonyl group, a p-toluenesulfonic acid group, and P1 and Ρ3 are as defined above;
式 6所示化合物在碱性条件下关环得到化合物 5,
Figure imgf000029_0005
其中: Pl、 P3如上所述定义;
The compound of formula 6 is ring-closed under basic conditions to give compound 5,
Figure imgf000029_0005
Where: Pl, P3 are defined as described above;
原得到式 4所示化合物,
Figure imgf000030_0001
Originally obtained a compound of the formula 4,
Figure imgf000030_0001
其中: PI, P3如上所述定义; Where: PI, P3 are defined as described above;
Bestmaim-Ohira试剂反应得到式 3所示化合物,
Figure imgf000030_0002
The Bestmaim-Ohira reagent reacts to give a compound of formula 3,
Figure imgf000030_0002
其中: PI , P3如上所述定义; Where: PI, P3 are defined as described above;
式 3所示化合物与羟基保护试剂反应得到式 2所示化合物。 The compound of the formula 3 is reacted with a hydroxy protecting reagent to give a compound of the formula 2.
4.权利要求 3歩骤 i中式 5所示化合物, 其制备方法如下: 4. The compound of formula 3, wherein the compound of formula 5 is prepared as follows:
试剂反应得到式 22所示化合物,
Figure imgf000030_0003
Reagent reaction to give a compound of formula 22,
Figure imgf000030_0003
22  twenty two
其中: R1为 C1- 6嫁基、 芳基、 取代的芳基以及芳垸基; Wherein: R1 is a C1- 6 graft group, an aryl group, a substituted aryl group, and an aryl fluorenyl group;
试剂反应生成式 21所示化合物,
Figure imgf000030_0004
Reagent reaction to form a compound of formula 21,
Figure imgf000030_0004
其中: R2为羟基活化基团, R1如上所述定义; Wherein: R2 is a hydroxyl activating group, and R1 is as defined above;
与 代试剂反应制备式 20所示化合物,
Figure imgf000030_0005
Preparing a compound of formula 20 by reacting with a reagent,
Figure imgf000030_0005
20  20
其中: X为卤素, 优选溴; R1如上所述定义; 式 20所示化合物与乙酰氨基丙二酸二乙酯在碱性试剂存在下反应得到式 19化合 物, Wherein: X is a halogen, preferably bromine; R1 is as defined above; The compound of formula 20 is reacted with diethyl acetylaminomalonate in the presence of an alkaline reagent to give a compound of formula 19,
AcHN COOB 19  AcHN COOB 19
其中: R1定义如上所述; Where: R1 is defined as described above;
式 19所示化合物醇解脱羧得式 18所示化合物; The compound of formula 19 is decarboxylated by alcohol to give a compound of formula 18;
^- NHAc  ^- NHAc
COOH  COOH
i l  i l
式 18所示化合物在 L-乙酰化酶条件下拆分, 再上保护基得到式 Π所示化合物,The compound of the formula 18 is resolved under the conditions of L-acetylase, and the protecting group is further added to obtain a compound of the formula:
HO-^ HO-^
17 17
其中: PI, P3定义如上所述定义;Where: PI, P3 are defined as defined above;
lar催化剂存在下加 S得式 16所示化合物,
Figure imgf000031_0001
Adding S to the compound of formula 16 in the presence of a lar catalyst,
Figure imgf000031_0001
16  16
其中: Pl, P3定义如上所述定义; Where: Pl, P3 are defined as defined above;
到式 15所示化合物,
Figure imgf000031_0002
To the compound of formula 15,
Figure imgf000031_0002
15  15
其中: X为卤素, Pl、 P3定义如上所述定义; Wherein: X is a halogen, and P1 and P3 are defined as defined above;
式 15所示化合物关环得到式 5所示化合物。 The compound of the formula 15 is ring-closed to give a compound of the formula 5.
5.权利要求 1中所示化合物 2的制备方法, 其特征在于 : A process for the preparation of a compound 2 as shown in claim 1, which is characterized in that :
L- 脯氨酸与氨基保护试剂反应得到式 33所示化合物,
Figure imgf000032_0001
L-proline is reacted with an amino protecting reagent to give a compound of formula 33,
Figure imgf000032_0001
33  33
其中: PI如上所述定义;  Where: PI is as defined above;
式 33所示化合物通过 Mtsunobu反应后水解, 得到式 32所示化合 H;
Figure imgf000032_0002
The compound of the formula 33 is hydrolyzed by the Mtsunobu reaction to obtain the compound H represented by the formula 32;
Figure imgf000032_0002
32  32
式 32所示化合物 基保护得到式 31所示化合物,
Figure imgf000032_0003
Compound group represented by formula 32 is protected to give a compound of formula 31,
Figure imgf000032_0003
其中: Pl, P2如上所述定义;  Where: Pl, P2 are defined as described above;
羧基保护试剂反应得到式 30所示化合物,
Figure imgf000032_0004
The carboxy protecting reagent is reacted to obtain a compound of the formula 30,
Figure imgf000032_0004
30  30
其中: Rl、 Pi, P2如上所述定义;  Where: Rl, Pi, P2 are defined as described above;
式 30所示化合物在氧化得到式 29所示化合物,  The compound of formula 30 is oxidized to give a compound of formula 29,
P, P,
29  29
其中: Rl , PI, P2, 如上所述定义;  Where: Rl, PI, P2, as defined above;
式 29所示化合物水解或醇解得到式 28所示化合物,  Hydrolysis or alcoholysis of the compound of Formula 29 to give a compound of Formula 28,
OP2 NP,P3 OP 2 NP, P 3
26 其中: R2为氢、 有机金属离子如钠、 锂、 钾离子以及烷基、 芳烷基、 芳环 上被取代的芳烷基, Rl、 Pl、 P2 如上所述定义; 26 Wherein: R2 is hydrogen, an organic metal ion such as sodium, lithium, potassium ion, and an alkyl group, an aralkyl group, an substituted aralkyl group on the aromatic ring, and R1, P1, and P2 are as defined above;
原得到式 27所示化合物,
Figure imgf000033_0001
Originally obtained a compound of the formula 27,
Figure imgf000033_0001
27  27
其中: Rl、 Pi, P2、 P3如上所述定义; Where: Rl, Pi, P2, P3 are defined as described above;
Wittig试剂反应得到式 26所示化合物,
Figure imgf000033_0002
Wittig reagent reaction gives the compound of formula 26,
Figure imgf000033_0002
其中: Rl、 Pl、 P2、 P3如上所 ¾定义; Where: Rl, Pl, P2, P3 are defined as above;
式 26所示化合物还原得到式 25所示化合物,
Figure imgf000033_0003
Reduction of the compound of Formula 26 to give a compound of Formula 25,
Figure imgf000033_0003
其中: Pl、 P2、 P3如上所述定义; 式 25所示化合物与 BestmamwiMra试前反应得到式 24所示化合物, Wherein: Pl, P2, P3 are as defined above; the compound of formula 25 is reacted with BestmamwiMra to give a compound of formula 24,
0P2 ΝΡ3Ρ, 0P 2 ΝΡ 3 Ρ,
24  twenty four
其中: ΡΚ Ρ2、 Ρ3如上所述定义; Where: ΡΚ Ρ 2, Ρ 3 are defined as described above;
式 24所示化合物氧化得到式 2所示化合物。 The compound of the formula 24 is oxidized to give a compound of the formula 2.
6. 式 1所示化合物。
Figure imgf000033_0004
Figure imgf000034_0001
6. A compound of formula 1.
Figure imgf000033_0004
Figure imgf000034_0001
2  2
其中: 环氧立体构型可为 R-构型, S-构型或 R,S-构型 。 Wherein: the epoxy stereo configuration can be R-configuration, S-configuration or R, S-configuration.
PCT/CN2013/089175 2013-01-14 2013-12-12 Entecavir intermediates and preparation method thereof WO2014108011A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201310011620.0A CN103387587B (en) 2013-01-14 2013-01-14 Entecavir midbodies and preparation method thereof
CN201310011620.0 2013-01-14

Publications (1)

Publication Number Publication Date
WO2014108011A1 true WO2014108011A1 (en) 2014-07-17

Family

ID=49532019

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2013/089175 WO2014108011A1 (en) 2013-01-14 2013-12-12 Entecavir intermediates and preparation method thereof

Country Status (2)

Country Link
CN (1) CN103387587B (en)
WO (1) WO2014108011A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103387587B (en) * 2013-01-14 2015-12-09 重庆康施恩化工有限公司 Entecavir midbodies and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106477A1 (en) * 2002-06-01 2003-12-24 Isis Pharmaceuticals, Inc. Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
CN101130542A (en) * 2006-08-24 2008-02-27 江苏正大天晴药业股份有限公司 Synthesis method of antiviral nucleoside analogue
CN101148450A (en) * 2007-11-02 2008-03-26 严红芳 Preparation method for nucleoside compounds
CN103387587A (en) * 2013-01-14 2013-11-13 重庆康施恩化工有限公司 Preparation method for entecavir intermediate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417506B (en) * 2010-09-27 2016-04-06 杭州赛利药物研究所有限公司 A kind of preparation method of antiviral drug of Entecavir

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003106477A1 (en) * 2002-06-01 2003-12-24 Isis Pharmaceuticals, Inc. Oligomeric compounds that include carbocyclic nucleosides and their use in gene modulation
CN101130542A (en) * 2006-08-24 2008-02-27 江苏正大天晴药业股份有限公司 Synthesis method of antiviral nucleoside analogue
CN101148450A (en) * 2007-11-02 2008-03-26 严红芳 Preparation method for nucleoside compounds
CN103387587A (en) * 2013-01-14 2013-11-13 重庆康施恩化工有限公司 Preparation method for entecavir intermediate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DONDONI, A. ET AL.: "A convenient synthesis of iminosugar-C-glycosides via organometallic addition to N-benzyl-N-glycosy lhydroxylamines", TETRAHEDRON, vol. 59, no. 24, 2003, pages 4261 - 4273 *

Also Published As

Publication number Publication date
CN103387587A (en) 2013-11-13
CN103387587B (en) 2015-12-09

Similar Documents

Publication Publication Date Title
JP5202635B2 (en) Processes and intermediates for the preparation of integrase inhibitors
CN102630226B (en) Entecavir synthesis method and intermediate compound thereof
JP2013047248A (en) Process and intermediates for preparing integrase inhibitor
WO2021175296A1 (en) Intermediate of remdesivir and preparation method therefor
CN102952011A (en) New synthetic method of carane aldehyde acid lactone, caronic acid, caronic anhydride and key intermediates thereof
CN104163759A (en) New synthesis methods of caronic acid and caronic anhydride
JP2013170151A (en) Direct method for producing indole-3-triflone and indole triflone derivative
WO2017219917A1 (en) Method for preparing trabectedin and intermediates thereof
WO2022107755A1 (en) Novel acridinium salt and method for producing same
WO2014108011A1 (en) Entecavir intermediates and preparation method thereof
CN112812147A (en) Synthetic method of abiraterone acetate and intermediate thereof
CN114605311B (en) Process for the preparation of intermediates of the drug nitratrelvir useful in the treatment of novel coronaviruses
KR20160026720A (en) Method for producing ether compound
JP2005272338A (en) Method for producing pyridine derivative
CN104829588B (en) A kind of Preparation Method And Their Intermediate of benzo [b] thiophene
JPWO2014051077A1 (en) Method for producing high purity nitrogen-containing heterocyclic compound
JPS58134092A (en) Theobromine derivative
CN111848552B (en) Preparation method and application of 3- (substituted phenyl) oxetane-3-carboxylic acid and intermediate thereof
WO2018108130A1 (en) Process for preparation of novel androgen receptor antagonist
CN103421032B (en) A kind of bortezomib intermediate and its preparation method and application
WO2023168827A1 (en) Synthesis method for paxlovid intermediate
CN111909040A (en) Preparation method of Elagolix intermediate 2-fluoro-6-trifluoromethylbenzylamine
TWI668220B (en) Synthetic method of entecavir and intermediate compounds thereof
WO2022082337A1 (en) Process of preparing 3-fluoro-5 ( ( (1r, 2ar) -3, 3, 4, 4-tetrafluoro-1, 2a-dihydroxy-2, 2a, 3, 4-tetrahydro-1h-cyclopenta [cd] inden-7-yl) oxy) benzonitrile
TW202311275A (en) Method for producing alkylsilyloxy substituted benzyl compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13870466

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 08-01-2016)

122 Ep: pct application non-entry in european phase

Ref document number: 13870466

Country of ref document: EP

Kind code of ref document: A1